Primary ciliary dyskinesia 30 (CILD30) is the form of PCD caused by biallelic loss-of-function variants in ODAD3, the gene formerly called CCDC151. The protein is a subunit of the outer dynein arm docking complex - the structure that anchors preassembled outer dynein arms onto the axonemal microtubules. Losing it does not damage the dynein motors themselves; it removes the place they attach. The result is a fully built cilium with nothing to power it. The lesion is unusually legible in the cell. In patients' respiratory cilia, ODAD3 is absent from the axoneme, and so are the two other docking-complex members ODAD1 (CCDC114) and ODAD2 (ARMC4) and the outer-arm heavy chain DNAH5, while inner dynein arms remain in place. That selective picture - outer arms gone, inner arms present - is what transmission electron microscopy reports as isolated outer dynein arm loss, and it is why the docking complex, rather than dynein assembly, is the level at which this disease acts. ODAD3 co-immunoprecipitates ODAD1, so the docking complex is understood to fail as a unit. Clinically this produces conventional PCD: lifelong wet cough, recurrent upper and lower airway infection, chronic rhinosinusitis, otitis media, bronchiectasis, and - because the same axonemal machinery drives the embryonic node's motile monocilia - laterality defects, which the defining series reports in its patients without giving a fraction in its abstract. Fewer than a dozen patients have been reported. Two things make this entity worth curating separately rather than as one more gene on the umbrella PCD entry, and both concern what happens outside the airway. The mouse null is perinatally lethal with communicating hydrocephalus, a phenotype that human ODAD3 patients do not have; and mouse work has followed the gene into spermatogenesis far enough to find a heterozygote effect - a gene-dosage claim with counselling implications that no human study has examined. Both are curated here with their translational limits stated explicitly rather than transferred to patients.
Ask a research question about Primary Ciliary Dyskinesia 30. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
Conditions with similar clinical presentations that must be differentiated from Primary Ciliary Dyskinesia 30:
name: Primary Ciliary Dyskinesia 30
creation_date: "2026-08-28T00:00:00Z"
category: Genetic
disease_term:
preferred_term: Primary ciliary dyskinesia 30
term:
id: MONDO:0014465
label: primary ciliary dyskinesia 30
description: >-
Primary ciliary dyskinesia 30 (CILD30) is the form of PCD caused by biallelic
loss-of-function variants in ODAD3, the gene formerly called CCDC151. The
protein is a subunit of the outer dynein arm docking complex - the structure
that anchors preassembled outer dynein arms onto the axonemal microtubules.
Losing it does not damage the dynein motors themselves; it removes the place
they attach. The result is a fully built cilium with nothing to power it.
The lesion is unusually legible in the cell. In patients' respiratory cilia,
ODAD3 is absent from the axoneme, and so are the two other docking-complex
members ODAD1 (CCDC114) and ODAD2 (ARMC4) and the outer-arm heavy chain DNAH5,
while inner dynein arms remain in place. That selective picture - outer arms
gone, inner arms present - is what transmission electron microscopy reports as
isolated outer dynein arm loss, and it is why the docking complex, rather than
dynein assembly, is the level at which this disease acts. ODAD3
co-immunoprecipitates ODAD1, so the docking complex is understood to fail as a
unit.
Clinically this produces conventional PCD: lifelong wet cough, recurrent upper
and lower airway infection, chronic rhinosinusitis, otitis media,
bronchiectasis, and - because the same axonemal machinery drives the embryonic
node's motile monocilia - laterality defects, which the defining series
reports in its patients without giving a fraction in its abstract. Fewer than a
dozen patients have been reported.
Two things make this entity worth curating separately rather than as one more
gene on the umbrella PCD entry, and both concern what happens outside the
airway. The mouse null is perinatally lethal with communicating hydrocephalus,
a phenotype that human ODAD3 patients do not have; and mouse work has followed
the gene into spermatogenesis far enough to find a heterozygote effect - a
gene-dosage claim with counselling implications that no human study has
examined. Both are curated here with their translational limits stated
explicitly rather than transferred to patients.
parents:
- Primary Ciliary Dyskinesia
- Ciliopathy
synonyms:
- CILD30
- ciliary dyskinesia, primary, 30, with or without situs inversus
- ODAD3-related primary ciliary dyskinesia
- CCDC151-related primary ciliary dyskinesia
- CCDC151 deficiency
classifications:
harrisons_chapter:
- classification_value: RESPIRATORY
notes: >-
The dominant clinical burden is chronic suppurative airway disease and
bronchiectasis.
- classification_value: GENETICS_ENVIRONMENT_DISEASE
notes: >-
A Mendelian recessive disorder identified and confirmed by sequencing.
mechanistic_category:
- classification_value: ciliopathy
references:
- reference: PMID:25192045
title: "CCDC151 mutations cause primary ciliary dyskinesia by disruption of the outer dynein arm docking complex formation."
- reference: PMID:25224326
title: "Nonsense mutation in coiled-coil domain containing 151 gene (CCDC151) causes primary ciliary dyskinesia."
- reference: PMID:33719352
title: "Case Report: Identification of a Novel ODAD3 Variant in a Patient With Primary Ciliary Dyskinesia."
- reference: PMID:32490514
title: "Identification of a frame shift mutation in the CCDC151 gene in a Han-Chinese family with Kartagener syndrome."
- reference: PMID:30504913
title: "Whole-exome sequencing identifies a novel CCDC151 mutation, c.325G>T (p.E109X), in a patient with primary ciliary dyskinesia and situs inversus."
- reference: PMID:31383820
title: "Functional loss of Ccdc151 leads to hydrocephalus in a mouse model of primary ciliary dyskinesia."
- reference: PMID:38920681
title: "The Odad3 Gene Is Necessary for Spermatozoa Development and Male Fertility in Mice."
- reference: PMID:24067530
title: "The coiled-coil domain containing protein CCDC151 is required for the function of IFT-dependent motile cilia in animals."
- reference: PMID:27486780
title: "TTC25 Deficiency Results in Defects of the Outer Dynein Arm Docking Machinery and Primary Ciliary Dyskinesia with Left-Right Body Asymmetry Randomization."
- reference: PMID:20301301
title: "Primary Ciliary Dyskinesia."
tags:
- GeneReviews
- reference: ORPHA:244
title: "Primary ciliary dyskinesia"
external_assertions:
- name: OMIM primary ciliary dyskinesia 30 record
source: OMIM
assertion_type: disease_record
external_id: OMIM:616037
description: >-
OMIM's record for CILD30, the ODAD3-related form of primary ciliary
dyskinesia. Recorded here because the identifier is easy to get wrong: the
deep-research report committed with this entry cites the umbrella primary
ciliary dyskinesia number, 244400, instead.
evidence:
- reference: PMID:33719352
reference_title: "Case Report: Identification of a Novel ODAD3 Variant in a Patient With Primary Ciliary Dyskinesia."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Up to now, PCD caused by ODAD3 variants (MIM 616037, CILD30) are rarely
reported
explanation: >-
Ties the OMIM identifier and the CILD30 designation to ODAD3-related
disease specifically. Graded OTHER because it is a background statement
rather than a finding of the citing study.
inheritance:
- name: Autosomal recessive inheritance
inheritance_term:
preferred_term: Autosomal recessive inheritance
term:
id: HP:0000007
label: Autosomal recessive inheritance
description: >-
Every reported patient carries two ODAD3 loss-of-function alleles. The
defining series found them in five affected individuals from three
independent families by combined mapping and sequencing; subsequent reports
are homozygous cases from consanguineous families. Nothing in the human
literature suggests a heterozygous carrier phenotype - see the discussion
below on why the mouse data raise that question anyway.
evidence:
- reference: PMID:25192045
reference_title: "CCDC151 mutations cause primary ciliary dyskinesia by disruption of the outer dynein arm docking complex formation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Here, by combined high-throughput mapping and sequencing, we identified
CCDC151 loss-of-function mutations in five affected individuals from three
independent families whose cilia showed a complete loss of ODAs and
severely impaired ciliary beating.
explanation: >-
Establishes recessive loss-of-function inheritance in the defining
families.
- reference: PMID:25224326
reference_title: "Nonsense mutation in coiled-coil domain containing 151 gene (CCDC151) causes primary ciliary dyskinesia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We observed a novel nonsense mutation in a homozygous state in the CCDC151
gene
explanation: >-
An independent homozygous case confirming the recessive mode. The snippet
stops before the variant's HGVS string because the protein change is
written with square brackets, which the reference validator strips before
matching; the allele itself is recorded in the genetic notes.
pathophysiology:
- name: Biallelic ODAD3 Loss of Function
biological_scale: MOLECULAR
role: trigger
mechanism_confidence: ESTABLISHED
description: >-
The initiating lesion. ODAD3 encodes a 595-amino-acid protein with three
highly conserved coiled-coil domains, and every reported disease allele is
loss-of-function. Seven had been reported as of the 2021 review cited below:
three nonsense, three frameshift, and - the one that does not fit a simple
truncation story - a canonical splice-donor variant, c.244+1G>A.
No missense allele has been reported. That matters for variant
interpretation, because it leaves no worked example of an ODAD3 change that
alters the protein without destroying it, and so nothing to calibrate a new
missense variant against. The splice-donor allele is the nearest thing
available and is not close: donor-site loss usually produces exon skipping or
intron retention with a frameshifted, decay-prone transcript, which lands
back in the same functional class rather than giving a graded one. So the
disease as described remains the phenotype of complete protein loss, and
nothing is known about partial loss in humans.
genes:
- preferred_term: ODAD3
term:
id: hgnc:28303
label: ODAD3
genetic_context:
functional_impact_category: LOSS_OF_FUNCTION
variant_origin: GERMLINE
description: >-
Curated as loss of function on the strength of the allele classes reported
- three nonsense, three frameshift and one canonical splice-donor variant -
together with the measured consequence: ODAD3 protein is absent from
patients' respiratory cilia. `zygosity` is left unset at the
disease level because reported patients are variously homozygous and
compound heterozygous.
evidence:
- reference: PMID:25192045
reference_title: "CCDC151 mutations cause primary ciliary dyskinesia by disruption of the outer dynein arm docking complex formation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We demonstrate that CCDC151 encodes an axonemal coiled coil protein,
mutations in which abolish assembly of CCDC151 into respiratory cilia
explanation: >-
States both the protein's nature and the immediate molecular consequence of
the variants.
- reference: PMID:33719352
reference_title: "Case Report: Identification of a Novel ODAD3 Variant in a Patient With Primary Ciliary Dyskinesia."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
ODAD3 encodes a protein of 595 amino acids and contain three highly
conserved coiled-coil domains, which is essential for cilia axoneme dynein
arm assembly and docking.
explanation: >-
Describes the protein architecture that the loss-of-function alleles
disrupt. Graded OTHER because it is background prose from the paper's
introduction rather than a finding from its study.
- reference: PMID:33719352
reference_title: "Case Report: Identification of a Novel ODAD3 Variant in a Patient With Primary Ciliary Dyskinesia."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
To date, a total of seven likely loss-of-function variants in ODAD3 have
been reported in PCD (Supplementary Table 2).
explanation: >-
The allelic spectrum as of 2021, and the reason this node says
"loss-of-function" rather than "nonsense or frameshift" - the seven include
a splice-donor variant that is neither. Graded OTHER because it is the
paper's survey of prior reports rather than its own finding.
downstream:
- target: Outer Dynein Arm Docking Complex Assembly Failure
causal_link_type: DIRECT
- name: Outer Dynein Arm Docking Complex Assembly Failure
biological_scale: MOLECULAR
role: central_effector
mechanism_confidence: ESTABLISHED
description: >-
The step that defines the disease. The ODA docking complex is a multi-subunit
structure, and ODAD3's loss takes the rest of it with it: in patients'
respiratory cilia the docking-complex members ODAD1 (CCDC114) and ODAD2
(ARMC4) fail to assemble onto the axoneme along with ODAD3 itself. The
physical basis for the co-dependence is that ODAD3 and ODAD1 are binding
partners - they co-immunoprecipitate.
The functional distinction worth holding onto: outer dynein arms are
*produced and preassembled in the cytosol* and then transported into the
cilium, so a docking-complex defect is not a failure to build motors. It is a
failure to install them.
biological_processes:
- preferred_term: axonemal dynein complex assembly
term:
id: GO:0070286
label: axonemal dynein complex assembly
modifier: DECREASED
cell_types:
- preferred_term: multiciliated respiratory epithelial cell
term:
id: CL:0005012
label: multiciliated epithelial cell
evidence:
- reference: PMID:25192045
reference_title: "CCDC151 mutations cause primary ciliary dyskinesia by disruption of the outer dynein arm docking complex formation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
cause a failure in axonemal assembly of the ODA component DNAH5 and the
ODA-DC-associated components CCDC114 and ARMC4
explanation: >-
The core observation: losing ODAD3 removes the rest of the docking complex
and the outer-arm heavy chain from the axoneme.
- reference: PMID:25192045
reference_title: "CCDC151 mutations cause primary ciliary dyskinesia by disruption of the outer dynein arm docking complex formation."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
Furthermore, CCDC151 coimmunoprecipitates CCDC114 and thus appears to be a
highly evolutionarily conserved ODA-DC-related protein involved in
mediating assembly of both ODAs and their axonemal docking machinery onto
ciliary microtubules.
explanation: >-
The physical interaction that explains why the docking complex fails as a
unit.
- reference: PMID:25192045
reference_title: "CCDC151 mutations cause primary ciliary dyskinesia by disruption of the outer dynein arm docking complex formation."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Multisubunit outer dynein arm (ODA) motor complexes, produced and
preassembled in the cytosol, are transported to the ciliary or flagellar
compartment and anchored into the axonemal microtubular scaffold via the
ODA docking complex (ODA-DC) system.
explanation: >-
Establishes that the motors are preassembled elsewhere, which is what makes
this an installation defect rather than an assembly defect. Graded OTHER
because it is background from the paper's introduction.
downstream:
- target: Absence of Outer Dynein Arms from the Axoneme
causal_link_type: DIRECT
- name: Absence of Outer Dynein Arms from the Axoneme
biological_scale: CELLULAR
role: central_effector
mechanism_confidence: ESTABLISHED
description: >-
The structural endpoint, and the one a diagnostic laboratory sees. Patients'
cilia show a complete loss of outer dynein arms on electron microscopy. The
arms are what generate most of the sliding force between axonemal doublets,
so their absence is sufficient to explain the beat failure without invoking
any additional lesion.
cell_types:
- preferred_term: multiciliated respiratory epithelial cell
term:
id: CL:0005012
label: multiciliated epithelial cell
locations:
- preferred_term: bronchus
term:
id: UBERON:0002185
label: bronchus
evidence:
- reference: PMID:25192045
reference_title: "CCDC151 mutations cause primary ciliary dyskinesia by disruption of the outer dynein arm docking complex formation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
we identified CCDC151 loss-of-function mutations in five affected
individuals from three independent families whose cilia showed a complete
loss of ODAs and severely impaired ciliary beating
explanation: >-
The ultrastructural and functional observation in patients.
downstream:
- target: Motile Ciliary Beat Failure
causal_link_type: DIRECT
- name: Motile Ciliary Beat Failure
biological_scale: CELLULAR
role: effector
mechanism_confidence: ESTABLISHED
conforms_to: "ciliopathy_dysfunction#Motile Cilia Beat Dysfunction"
description: >-
Cilia that are assembled but cannot beat. In the airway this abolishes
mucociliary clearance; at the embryonic left-right organiser the same failure
in motile monocilia removes the directional flow that breaks symmetry. Both
limbs of the module node are evidenced here rather than assumed: the
ciliary-dysmotility half from patients' severely impaired beating, and the
laterality half from expression of Ccdc151 in vertebrate left-right
organisers together with the situs defects seen in patients and in three
model species.
Conformance note: this node matches the module's motile-cilia node directly
and completely, which is the expected shape for a classical axonemal PCD
gene. It is a different relationship from the one the module has with the
reduced-generation-of-multiple-motile-cilia forms of PCD, where the cilia are
too few rather than immotile.
biological_processes:
- preferred_term: cilium movement
term:
id: GO:0003341
label: cilium movement
modifier: ABNORMAL
- preferred_term: determination of left/right symmetry
term:
id: GO:0007368
label: determination of left/right symmetry
modifier: ABNORMAL
cell_types:
- preferred_term: multiciliated respiratory epithelial cell
term:
id: CL:0005012
label: multiciliated epithelial cell
evidence:
- reference: PMID:25192045
reference_title: "CCDC151 mutations cause primary ciliary dyskinesia by disruption of the outer dynein arm docking complex formation."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Consistent with the laterality defects observed in these individuals, we
found Ccdc151 expressed in vertebrate left-right organizers.
explanation: >-
Ties the laterality half of this node to the gene's expression at the
structure responsible for it. Graded MODEL_ORGANISM because the finding
reported is expression in vertebrate model organisms; the human laterality
defects it is consistent with are evidenced separately.
- reference: PMID:25192045
reference_title: "CCDC151 mutations cause primary ciliary dyskinesia by disruption of the outer dynein arm docking complex formation."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
In humans, defects in ODA assembly are the major cause of primary ciliary
dyskinesia (PCD), an inherited disorder of ciliary and flagellar
dysmotility characterized by chronic upper and lower respiratory infections
and defects in laterality.
explanation: >-
Places outer-dynein-arm defects as the major mechanism of PCD and names the
two clinical consequences this node produces. Graded OTHER because it is a
background statement about the disease class.
downstream:
- target: Mucociliary Clearance Failure
causal_link_type: DIRECT
- target: Randomised Left-Right Body Asymmetry
causal_link_type: DIRECT
- name: Mucociliary Clearance Failure
biological_scale: TISSUE
role: effector
mechanism_confidence: ESTABLISHED
description: >-
The immediate tissue-level consequence of cilia that cannot beat: the mucus
escalator stops. Nothing is yet infected or destroyed at this step - the
airway surface simply loses the directional fluid movement that normally
clears it, and with it the host defence that movement constitutes.
Curated as its own node rather than folded into the airway disease below
because it is the step a therapy would have to act on. Everything downstream
is secondary damage; this is the primary functional loss.
biological_processes:
- preferred_term: mucociliary clearance
term:
id: GO:0120197
label: mucociliary clearance
modifier: DECREASED
cell_types:
- preferred_term: multiciliated respiratory epithelial cell
term:
id: CL:0005012
label: multiciliated epithelial cell
evidence:
- reference: PMID:32490514
reference_title: "Identification of a frame shift mutation in the CCDC151 gene in a Han-Chinese family with Kartagener syndrome."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
In KS patients, defective fluid movement basing on cilia across the surface
of the respiratory airway multiciliated epithelial cell can impair the
mucociliary clearance host-defense mechanisms
explanation: >-
The mechanistic link from ciliary failure to impaired clearance. Graded
OTHER because it is background about Kartagener syndrome as a class rather
than an observation in the reported family.
downstream:
- target: Chronic Airway Infection and Neutrophilic Inflammation
causal_link_type: DIRECT
- name: Chronic Airway Infection and Neutrophilic Inflammation
biological_scale: TISSUE
role: amplifier
mechanism_confidence: ESTABLISHED
description: >-
Retained mucus is colonised, and the airway mounts a neutrophilic response
that never resolves because the stimulus is never cleared. This is the
self-sustaining middle of the disease and the reason it is progressive rather
than static: each cycle of infection recruits inflammation that damages the
airway, and the damaged airway clears even less well.
Typed as an amplifier for that reason. It is also the step at which the
disease becomes treatable in practice - airway clearance and antibiotics act
here, not on the axoneme - which is why it is worth having as a node even
though no ODAD3-specific study addresses it.
locations:
- preferred_term: bronchus
term:
id: UBERON:0002185
label: bronchus
evidence:
- reference: PMID:32490514
reference_title: "Identification of a frame shift mutation in the CCDC151 gene in a Han-Chinese family with Kartagener syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The patient in the present study presented with recurrent upper and lower
airways infections such as chronic cough, bronchiectasis, sinusitis, and
chest infections
explanation: >-
Recurrent infection of both airway compartments in a reported CCDC151
patient.
- reference: PMID:25192045
reference_title: "CCDC151 mutations cause primary ciliary dyskinesia by disruption of the outer dynein arm docking complex formation."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
an inherited disorder of ciliary and flagellar dysmotility characterized by
chronic upper and lower respiratory infections and defects in laterality
explanation: >-
Establishes chronic upper and lower respiratory infection as a defining
feature of the disease class this entity belongs to. Graded OTHER because
it is background from the paper's introduction.
downstream:
- target: Bronchiectasis and Airway Wall Destruction
causal_link_type: DIRECT
- name: Bronchiectasis and Airway Wall Destruction
biological_scale: ORGANISM
role: outcome
mechanism_confidence: ESTABLISHED
description: >-
The irreversible endpoint, and the reason early diagnosis matters: the
bronchial wall is destroyed by the inflammation above and does not recover.
Diffuse bronchiectasis is documented in the individually described 35-year-old
ODAD3 patient and in the Kartagener-syndrome case.
What is ODAD3-specific here is that clinical observation. The sequence that
produces it - retention, infection, inflammation, wall destruction - is the
general PCD mechanism, cited as such on the nodes above, and no study has
examined it in this genotype.
locations:
- preferred_term: bronchus
term:
id: UBERON:0002185
label: bronchus
evidence:
- reference: PMID:33719352
reference_title: "Case Report: Identification of a Novel ODAD3 Variant in a Patient With Primary Ciliary Dyskinesia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The 35 year-old female patient exhibited chronic sinusitis, diffuse
bronchiectasis, dextrocardia and infertility.
explanation: >-
The clinical picture in an individually described ODAD3 patient, including
the bronchiectasis this node records.
- name: Randomised Left-Right Body Asymmetry
biological_scale: ORGANISM
role: effector
mechanism_confidence: ESTABLISHED
description: >-
Laterality is not reversed by this disease; it is randomised. That is the
correct way to describe a nodal-flow defect and it explains the observed
spread - situs solitus, situs inversus totalis, and complex heterotaxy with
congenital heart disease all occur, and all three were seen in the vertebrate
models.
On frequency: the defining paper's abstract records laterality defects in the
reported individuals but gives no fraction, and its cached record is
abstract-only. The deep-research report committed with this entry, which read
the full text, records four of the five with a laterality defect and one with
a ventricular septal defect. That is an uncited lead, and with a denominator
of five it would in any case describe those three families rather than
estimate penetrance.
biological_processes:
- preferred_term: determination of left/right symmetry
term:
id: GO:0007368
label: determination of left/right symmetry
modifier: ABNORMAL
evidence:
- reference: PMID:25192045
reference_title: "CCDC151 mutations cause primary ciliary dyskinesia by disruption of the outer dynein arm docking complex formation."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Homozygous zebrafish ccdc151(ts272a) and mouse Ccdc151(Snbl) mutants
display a spectrum of situs defects associated with complex heart defects.
explanation: >-
Establishes that the laterality consequence is a spectrum rather than a
simple reversal, in two model species.
- reference: PMID:30504913
reference_title: "Whole-exome sequencing identifies a novel CCDC151 mutation, c.325G>T (p.E109X), in a patient with primary ciliary dyskinesia and situs inversus."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
our study provides additional support that CCDC151 plays important roles in
left-right patterning and ciliary function
explanation: >-
An independent human case with situs inversus supporting the laterality
role.
phenotypes:
- category: Cellular
name: Absent Outer Dynein Arms
description: >-
The diagnostic ultrastructural finding, and the phenotype that names the
mechanism. Outer arms are absent; inner arms are not. That selectivity is
what distinguishes an ODA or ODA-docking defect from the combined
inner-and-outer arm loss of the dynein-preassembly disorders, and it is
curated with the specific HPO term for absent outer arms rather than the
combined term for that reason.
phenotype_term:
preferred_term: Absent outer dynein arms
term:
id: HP:0012256
label: Absent outer dynein arms
evidence:
- reference: PMID:25192045
reference_title: "CCDC151 mutations cause primary ciliary dyskinesia by disruption of the outer dynein arm docking complex formation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
whose cilia showed a complete loss of ODAs and severely impaired ciliary
beating
explanation: >-
Documents complete outer dynein arm loss in the defining patients.
- category: Cellular
name: Abnormal Ciliary Motility
description: >-
Severely impaired ciliary beating in patients' respiratory cilia, and
dysmotility with outer-arm loss reproduced in three model species.
phenotype_term:
preferred_term: Abnormal ciliary motility
term:
id: HP:0012262
label: Abnormal ciliary motility
evidence:
- reference: PMID:25192045
reference_title: "CCDC151 mutations cause primary ciliary dyskinesia by disruption of the outer dynein arm docking complex formation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
whose cilia showed a complete loss of ODAs and severely impaired ciliary
beating
explanation: >-
Documents the beat defect in patients.
- reference: PMID:25192045
reference_title: "CCDC151 mutations cause primary ciliary dyskinesia by disruption of the outer dynein arm docking complex formation."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
CCDC151-deficient zebrafish, planaria, and mice also display ciliary
dysmotility accompanied by ODA loss.
explanation: >-
Cross-species reproduction of the same coupled defect.
- category: Respiratory
name: Bronchiectasis
frequency: FREQUENT
description: >-
Diffuse bronchiectasis, the irreversible structural consequence of chronic
retained infection. Documented in the individually described 35-year-old
ODAD3 patient.
phenotype_term:
preferred_term: Bronchiectasis
term:
id: HP:0002110
label: Bronchiectasis
evidence:
- reference: PMID:33719352
reference_title: "Case Report: Identification of a Novel ODAD3 Variant in a Patient With Primary Ciliary Dyskinesia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The 35 year-old female patient exhibited chronic sinusitis, diffuse
bronchiectasis, dextrocardia and infertility.
explanation: >-
Documents bronchiectasis in a reported ODAD3 patient.
- reference: ORPHA:244
reference_title: "Primary ciliary dyskinesia"
supports: SUPPORT
evidence_source: OTHER
snippet: "HP:0002110 | Bronchiectasis | Occasional (29-5%)"
explanation: >-
Graded PARTIAL because the band understates this phenotype rather than
measuring it: Orphanet's Occasional is a class figure that most likely
reflects cross-sectional point prevalence rather than cumulative
incidence, and both individually described ODAD3 patients have
bronchiectasis. `frequency` is set to FREQUENT on that gene-specific
evidence, matching how the umbrella `Primary Ciliary Dyskinesia` entry
handles this same Orphanet row.
- category: Respiratory
name: Recurrent Respiratory Infections
frequency: FREQUENT
description: >-
Upper and lower airway infection from infancy onwards - the consequence of
losing mucociliary clearance, and the burden that eventually produces the
bronchiectasis curated above. Documented in two independently reported ODAD3
patients.
phenotype_term:
preferred_term: Recurrent respiratory infections
term:
id: HP:0002205
label: Recurrent respiratory infections
temporality: RECURRENT
evidence:
- reference: PMID:33719352
reference_title: "Case Report: Identification of a Novel ODAD3 Variant in a Patient With Primary Ciliary Dyskinesia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
She has been inflicted by recurrent infections of the lower and upper
airways since newborn.
explanation: >-
Lifelong recurrent airway infection in the reported ODAD3 patient, from the
newborn period.
- reference: PMID:32490514
reference_title: "Identification of a frame shift mutation in the CCDC151 gene in a Han-Chinese family with Kartagener syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The patient in the present study presented with recurrent upper and lower
airways infections such as chronic cough, bronchiectasis, sinusitis, and
chest infections
explanation: >-
The same picture in an independently reported CCDC151 patient.
- reference: ORPHA:244
reference_title: "Primary ciliary dyskinesia"
supports: SUPPORT
evidence_source: OTHER
snippet: "HP:0005425 | Recurrent sinopulmonary infections | Frequent (79-30%)"
explanation: >-
Graded PARTIAL because the row is not this phenotype's own term. Orphanet
grades HP:0005425 recurrent sinopulmonary infections, which is narrower
than the HP:0002205 recurrent respiratory infections bound here; it is the
nearest graded row in the table and is what the FREQUENT band rests on.
Recorded explicitly so the mismatch is visible rather than implied.
- category: Respiratory
name: Productive Cough
frequency: FREQUENT
description: >-
The chronic wet cough that is the day-to-day clinical signature of impaired
mucociliary clearance, and usually the earliest persistent symptom.
phenotype_term:
preferred_term: Productive cough
term:
id: HP:0031245
label: Productive cough
temporality: CHRONIC
evidence:
- reference: PMID:32490514
reference_title: "Identification of a frame shift mutation in the CCDC151 gene in a Han-Chinese family with Kartagener syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The proband, a 34-year-old male with chief complaints of recurrent
productive cough and intermittent fever, was admitted to the Third Xiangya
Hospital, Central South University, Changsha, China.
explanation: >-
Productive cough as the presenting complaint in the reported CCDC151
patient.
- reference: ORPHA:244
reference_title: "Primary ciliary dyskinesia"
supports: SUPPORT
evidence_source: OTHER
snippet: "HP:0031245 | Productive cough | Frequent (79-30%)"
explanation: >-
Orphanet's frequency band for productive cough in primary ciliary
dyskinesia as a class. Not an ODAD3-specific figure.
- category: Cardiovascular
name: Ventricular Septal Defect
frequency: OCCASIONAL
description: >-
Congenital heart disease is part of the laterality arm rather than a separate
lesion: disturbed left-right patterning at the embryonic node produces
complex cardiac malformations as well as situs abnormalities, and the animal
models show situs defects and complex heart defects together. Reported among
the phenotypes seen in CCDC151 patients.
Graded OCCASIONAL rather than left unqualified, deliberately. The source
sentence lists this among "varied" phenotypes and adds its own caveat that
the variation may reflect background genotype effects, epigenetic
modifications and environmental factors - so it is describing a phenotype
that appears in some CCDC151 patients and not others, without giving a count.
OCCASIONAL is the most that supports; a higher band would read a frequency
into a sentence that declines to give one.
phenotype_term:
preferred_term: Ventricular septal defect
term:
id: HP:0001629
label: Ventricular septal defect
evidence:
- reference: PMID:32490514
reference_title: "Identification of a frame shift mutation in the CCDC151 gene in a Han-Chinese family with Kartagener syndrome."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Affected individuals with CCDC151 mutations also showed varied phenotypes,
including dextrocardia, SI, cardiac ventricular septal defect and hearing
disease
explanation: >-
A gene-specific summary of the reported CCDC151 phenotype range naming
ventricular septal defect. Graded OTHER because it summarises the primary
reports rather than describing the citing paper's own patient.
- category: Otological
name: Hearing Impairment
frequency: OCCASIONAL
description: >-
Conductive hearing loss follows from middle-ear disease, which follows from
the same ciliated epithelium failing in the Eustachian tube. Recorded here
from the gene-specific phenotype summary rather than from an individually
described patient, and graded OCCASIONAL for the same reason as the
ventricular septal defect above: the source lists it among varied phenotypes
and attributes the variation to background genotype, epigenetic and
environmental effects without giving a count.
Note the term chosen is the general hearing-impairment term rather than a
conductive-specific one. The mechanism above predicts conductive loss, but
the source says only "hearing disease", and binding to the more specific term
would assert an audiological characterisation nobody reported.
phenotype_term:
preferred_term: Hearing impairment
term:
id: HP:0000365
label: Hearing impairment
evidence:
- reference: PMID:32490514
reference_title: "Identification of a frame shift mutation in the CCDC151 gene in a Han-Chinese family with Kartagener syndrome."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Affected individuals with CCDC151 mutations also showed varied phenotypes,
including dextrocardia, SI, cardiac ventricular septal defect and hearing
disease
explanation: >-
The same gene-specific phenotype summary, naming hearing disease. Graded
OTHER for the same reason.
- reference: ORPHA:244
reference_title: "Primary ciliary dyskinesia"
supports: SUPPORT
evidence_source: OTHER
snippet: "HP:0000365 | Hearing impairment | Occasional (29-5%)"
explanation: >-
Independent corroboration of the OCCASIONAL band already assigned here,
which was reasoned from a narrative hedge rather than from a graded
source. Orphanet reaches the same band for the class.
- reference: ORPHA:244
reference_title: "Primary ciliary dyskinesia"
supports: SUPPORT
evidence_source: OTHER
snippet: "HP:0000405 | Conductive hearing impairment | Occasional (29-5%)"
explanation: >-
Orphanet grades the conductive subtype at the same band, which supports
the mechanism this phenotype's description gives - middle-ear disease
following from the same ciliated epithelium failing in the Eustachian
tube - without changing the decision to bind the general HP:0000365 term,
since the sources describing ODAD3 patients say only "hearing disease".
- category: Respiratory
name: Chronic Sinusitis
frequency: FREQUENT
phenotype_term:
preferred_term: Chronic sinusitis
term:
id: HP:0011109
label: Chronic sinusitis
evidence:
- reference: PMID:33719352
reference_title: "Case Report: Identification of a Novel ODAD3 Variant in a Patient With Primary Ciliary Dyskinesia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The 35 year-old female patient exhibited chronic sinusitis, diffuse
bronchiectasis, dextrocardia and infertility.
explanation: >-
Documents chronic sinusitis in a reported ODAD3 patient.
- reference: ORPHA:244
reference_title: "Primary ciliary dyskinesia"
supports: SUPPORT
evidence_source: OTHER
snippet: "HP:0011109 | Chronic sinusitis | Frequent (79-30%)"
explanation: >-
Orphanet's frequency band for chronic sinusitis in the class. Not an
ODAD3-specific figure.
- category: Cardiovascular
name: Dextrocardia
description: >-
One manifestation of the randomised laterality this disease produces.
Recorded as dextrocardia rather than as situs inversus totalis because
dextrocardia is what the source states for this patient; the broader
laterality spectrum is curated as its own phenotype below.
phenotype_term:
preferred_term: Dextrocardia
term:
id: HP:0001651
label: Dextrocardia
evidence:
- reference: PMID:33719352
reference_title: "Case Report: Identification of a Novel ODAD3 Variant in a Patient With Primary Ciliary Dyskinesia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The 35 year-old female patient exhibited chronic sinusitis, diffuse
bronchiectasis, dextrocardia and infertility.
explanation: >-
Documents dextrocardia in a reported ODAD3 patient.
- category: Cardiovascular
name: Situs Inversus
frequency: FREQUENT
description: >-
Situs inversus is one outcome of randomised laterality, reported in an
independent Chinese case and in the Kartagener-syndrome family. It is not
obligate: the MONDO term for this disease is explicitly "with or without
situs inversus", and roughly half of PCD patients in general have normal
situs.
phenotype_term:
preferred_term: Situs inversus totalis
term:
id: HP:0001696
label: Situs inversus totalis
evidence:
- reference: PMID:30504913
reference_title: "Whole-exome sequencing identifies a novel CCDC151 mutation, c.325G>T (p.E109X), in a patient with primary ciliary dyskinesia and situs inversus."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We identified a novel CCDC151 mutation, c.325G>T (p.E109X), in a patient
with primary ciliary dyskinesia and situs inversus.
explanation: >-
An ODAD3 patient with situs inversus.
- reference: ORPHA:244
reference_title: "Primary ciliary dyskinesia"
supports: SUPPORT
evidence_source: OTHER
snippet: "HP:0001696 | Situs inversus totalis | Occasional (29-5%)"
explanation: >-
Graded PARTIAL because the band sits below what this entry itself states
and what the literature reports - roughly half of PCD patients have a
laterality defect, and situs inversus totalis is the commonest form of it.
`frequency` is set to FREQUENT accordingly, matching how the umbrella
`Primary Ciliary Dyskinesia` entry handles this same Orphanet row. The row
is still worth quoting because it is the only graded source available and
because a reader should see that the graded value and the narrative value
disagree.
- category: Otological
name: Recurrent Otitis Media
frequency: FREQUENT
description: >-
Middle-ear disease is part of the reported CILD30 picture, and it follows
from the same lesion: the Eustachian tube and middle-ear mucosa are lined by
the same motile-ciliated epithelium as the airway. Curated from a
gene-specific summary in a case report rather than from an individually
described patient, which is why the evidence is graded OTHER.
phenotype_term:
preferred_term: Recurrent otitis media
term:
id: HP:0000403
label: Recurrent otitis media
evidence:
- reference: PMID:32490514
reference_title: "Identification of a frame shift mutation in the CCDC151 gene in a Han-Chinese family with Kartagener syndrome."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Patients with CILD30 may have respiratory symptoms, nasal blockages, nasal
polyps, otitis media, and laterality defects
explanation: >-
A summary of the CILD30 phenotype naming otitis media. Graded OTHER
because it is a secondary summary of the primary reports rather than an
observation the citing paper made.
- reference: ORPHA:244
reference_title: "Primary ciliary dyskinesia"
supports: SUPPORT
evidence_source: OTHER
snippet: "HP:0000403 | Recurrent otitis media | Frequent (79-30%)"
explanation: >-
Orphanet's frequency band for the class, and independent corroboration
of a phenotype otherwise carried only by a gene-specific narrative
summary.
- category: Respiratory
name: Nasal Polyposis
frequency: FREQUENT
description: >-
Nasal obstruction and polyps in the upper airway, from the same
gene-specific summary as the otitis media above and with the same evidential
standing.
phenotype_term:
preferred_term: Nasal polyposis
term:
id: HP:0100582
label: Nasal polyposis
evidence:
- reference: PMID:32490514
reference_title: "Identification of a frame shift mutation in the CCDC151 gene in a Han-Chinese family with Kartagener syndrome."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Patients with CILD30 may have respiratory symptoms, nasal blockages, nasal
polyps, otitis media, and laterality defects
explanation: >-
The same CILD30 phenotype summary, naming nasal blockage and polyps.
- reference: ORPHA:244
reference_title: "Primary ciliary dyskinesia"
supports: SUPPORT
evidence_source: OTHER
snippet: "HP:0100582 | Nasal polyposis | Frequent (79-30%)"
explanation: >-
Orphanet's frequency band for the class, corroborating a phenotype
otherwise carried only by a narrative summary.
- category: Respiratory
name: Neonatal Respiratory Distress
frequency: FREQUENT
description: >-
Unexplained respiratory distress in a term neonate is the earliest
presentation of primary ciliary dyskinesia and one of the strongest reasons
to suspect it, because the usual causes of neonatal distress do not apply to
a term baby with no perinatal insult. Orphanet grades it Frequent across the
disease class.
On ODAD3 specifically: the deep-research report committed with this entry,
which read the defining paper's full text, records it in four of the five
patients of that series. That figure is an uncited lead - the paper's cached
record is abstract-only and its abstract does not carry it - so the graded
class-level band is what this phenotype is evidenced on, not the
gene-specific fraction.
phenotype_term:
preferred_term: Neonatal respiratory distress
term:
id: HP:0002643
label: Neonatal respiratory distress
onset:
onset_category: NEONATAL
evidence:
- reference: ORPHA:244
reference_title: "Primary ciliary dyskinesia"
supports: SUPPORT
evidence_source: OTHER
snippet: "HP:0002643 | Neonatal respiratory distress | Frequent (79-30%)"
explanation: >-
Orphanet's graded frequency for neonatal respiratory distress in primary
ciliary dyskinesia. The band is the class's, not ODAD3's.
- category: Reproductive
name: Male Infertility
frequency: FREQUENT
description: >-
Sperm flagella are motile axonemes carrying the same outer dynein arms and
the same docking complex as an airway cilium, so a docking-complex defect is
expected to impair them - and Orphanet grades male infertility Frequent
across primary ciliary dyskinesia, a band above the Occasional it gives
female infertility.
The gene-specific support here is unusually strong for a phenotype curated
from a class-level band, and it comes from the two mouse models this entry
already carries. The constitutive Ccdc151 null shows male infertility
alongside its laterality defects, and the adult Odad3 conditional deletion
produces asthenoteratozoospermia with multiple morphological abnormalities of
the sperm flagella. Neither is a human observation, which is why the class
band carries the phenotype and the model evidence is recorded beside it.
No ODAD3 male patient's fertility has been reported. That is a gap in the
literature rather than evidence of absence, and it is the same gap the
open discussion on heterozygous carriers turns on.
phenotype_term:
preferred_term: Male infertility
term:
id: HP:0003251
label: Male infertility
evidence:
- reference: ORPHA:244
reference_title: "Primary ciliary dyskinesia"
supports: SUPPORT
evidence_source: OTHER
snippet: "HP:0003251 | Male infertility | Frequent (79-30%)"
explanation: >-
Orphanet's graded frequency for male infertility in primary ciliary
dyskinesia, and the band that carries this phenotype. It is the class's,
not ODAD3's.
- reference: PMID:31383820
reference_title: "Functional loss of Ccdc151 leads to hydrocephalus in a mouse model of primary ciliary dyskinesia."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Congenital defects in left-right asymmetry and male infertility have been
also observed in Ccdc151-null animals.
explanation: >-
Gene-specific support from the constitutive null, which is what raises this
above a phenotype carried by a class band alone.
- category: Reproductive
name: Abnormal Sperm Motility
frequency: FREQUENT
description: >-
The mechanism behind the infertility above, and the level at which this
disease's lesion is directly visible in a gamete: the flagellar axoneme is
built without its outer dynein arms, so it cannot generate the sliding force
to beat.
Curated separately from male infertility because the two are not the same
claim and the models separate them. Deleting Odad3 in adult males gives
abnormal sperm morphology and motility short of complete azoospermia,
whereas the constitutive null has no sperm in the reproductive tract at all -
so motility failure and infertility can come apart depending on when the
gene is lost.
phenotype_term:
preferred_term: Abnormal sperm motility
term:
id: HP:0012206
label: Abnormal sperm motility
evidence:
- reference: ORPHA:244
reference_title: "Primary ciliary dyskinesia"
supports: SUPPORT
evidence_source: OTHER
snippet: "HP:0012206 | Abnormal sperm motility | Frequent (79-30%)"
explanation: >-
Orphanet's graded frequency for abnormal sperm motility in the class.
- reference: PMID:31383820
reference_title: "Functional loss of Ccdc151 leads to hydrocephalus in a mouse model of primary ciliary dyskinesia."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Ccdc151 gene deletion in adult animals results in abnormal sperm counts
and defective sperm motility.
explanation: >-
The adult-deletion measurement, which isolates the motility defect from the
developmental absence of sperm seen in the constitutive null.
- category: Reproductive
name: Female Infertility
frequency: OCCASIONAL
description: >-
Reported in the 35-year-old ODAD3 patient, and flagged by that paper as the
first such report for this gene. Female subfertility in PCD is attributed to
the motile cilia of the fallopian tube rather than to a gamete defect, but
that attribution was not tested in this patient, so the node records the
observation rather than the mechanism.
phenotype_term:
preferred_term: Female infertility
term:
id: HP:0008222
label: Female infertility
evidence:
- reference: PMID:33719352
reference_title: "Case Report: Identification of a Novel ODAD3 Variant in a Patient With Primary Ciliary Dyskinesia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The 35 year-old female patient exhibited chronic sinusitis, diffuse
bronchiectasis, dextrocardia and infertility.
explanation: >-
Records infertility in the reported female patient. The paper separately
states that female infertility in ODAD3-related PCD had not previously been
reported, but that sentence evidences novelty rather than the phenotype and
is not used here.
- reference: ORPHA:244
reference_title: "Primary ciliary dyskinesia"
supports: SUPPORT
evidence_source: OTHER
snippet: "HP:0008222 | Female infertility | Occasional (29-5%)"
explanation: >-
Orphanet grades female infertility Occasional for the class. Recorded
alongside the individually described ODAD3 patient, and worth comparing
with male infertility below, which Orphanet grades Frequent.
biochemical:
- name: Nasal Nitric Oxide
presence: Decreased
reference_ranges:
- lower_bound: 77.0
unit: nl/min
population: patients assessed for primary ciliary dyskinesia
notes: >-
A one-sided diagnostic threshold rather than a laboratory normal interval,
which is why `upper_bound` is unset: values at or above 77 nl/min argue
against PCD, and there is no upper limit at which the test becomes abnormal
again. `loinc_term` is likewise unset - nasal nitric oxide has no LOINC
code in the caches this repository carries, and inventing one would be
worse than leaving it out.
interpretation_bands:
- name: Below the PCD diagnostic cut-off
upper_bound: 77.0
unit: nl/min
abnormal_flag: LOW
interpretation: >-
Supports referral for ciliary ultrastructural and genetic testing. It
does not diagnose PCD on its own and says nothing about which gene. The
reported ODAD3 patient measured 6 nl/min, an order of magnitude below the
threshold rather than marginally under it.
- name: At or above the PCD diagnostic cut-off
lower_bound: 77.0
unit: nl/min
abnormal_flag: NORMAL
interpretation: >-
Argues against PCD, though it does not exclude it - some genotypes,
notably RSPH1, retain higher nasal nitric oxide.
evidence:
- reference: PMID:33719352
reference_title: "Case Report: Identification of a Novel ODAD3 Variant in a Patient With Primary Ciliary Dyskinesia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Her nasal nitric oxide concentration (nNO) (6 nl/min) was far below the
reference nNO cutoff value of PCD (77 nl/min)
explanation: >-
The source of both the cut-off and the patient value.
notes: >-
The first-line screening test for primary ciliary dyskinesia, and the one
ODAD3-specific diagnostic number that exists. Nasal nitric oxide is
characteristically very low in PCD for reasons that remain unsettled, and the
reported ODAD3 patient measured 6 nl/min against a PCD cut-off of 77 - not
marginally low but an order of magnitude below the threshold.
Curated here because it meets this entry's own standard, which the rest of
the entry applies strictly: it has been measured in this genotype. That makes
it stronger evidence than several class-level statements the entry does
carry, and omitting it while keeping those would have been inconsistent.
Two limits. It is one patient, so the value bounds nothing; and a low nasal
NO does not identify ODAD3 or even confirm PCD on its own - it selects
patients for the ultrastructural and genetic testing that does.
evidence:
- reference: PMID:33719352
reference_title: "Case Report: Identification of a Novel ODAD3 Variant in a Patient With Primary Ciliary Dyskinesia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Her nasal nitric oxide concentration (nNO) (6 nl/min) was far below the
reference nNO cutoff value of PCD (77 nl/min)
explanation: >-
The measured value in the reported ODAD3 patient, against the diagnostic
cut-off.
genetic:
- name: ODAD3
gene_term:
preferred_term: ODAD3
term:
id: hgnc:28303
label: ODAD3
relationship_type: CAUSATIVE
variant_origin: GERMLINE
presence: PRESENT
notes: >-
The gene's approved symbol changed from CCDC151 to ODAD3 when the outer
dynein arm docking complex members were renamed as a family (ODAD1 =
CCDC114, ODAD2 = ARMC4, ODAD3 = CCDC151, ODAD4 = TTC25). This matters for
literature searching: the defining 2014 paper, the mouse hydrocephalus model
and the zebrafish work are all published under CCDC151, while the 2021 case
report and the 2024 mouse fertility work use ODAD3. A search on either symbol
alone misses roughly half the literature.
Reported alleles, all loss-of-function. Quotable here: c.925G>T p.(Glu309*),
homozygous in a consanguineous Arabic family; c.325G>T p.(Glu109*) in
mainland China; c.167delG p.(Gly56Aspfs*26) in a Han-Chinese Kartagener
family; and c.1166_1169dupAGAC p.(Leu391Aspfs*105) in a consanguineous
Chinese family.
The defining 2014 series' own two alleles are reported but not quotable,
because that paper's cached record is abstract-only and its abstract gives no
variant. As uncited leads from the deep-research report committed with this
entry, which read the full text: c.925G>T p.(Glu309*) - the same allele
independently reported above - in two unrelated Arabic-origin pedigrees, and
c.1256C>A p.(Ser419*) in a consanguineous UK-Pakistani family.
Both of those alleles are transcribed inconsistently in the secondary
literature, in two independent ways, and a curator should expect it. At the
nucleotide level the deep-research report warns that some summaries render
the second change as C>T where the primary full text gives C>A. At the
protein level the 2021 review cited on the trigger node lists the same two
Hjeij alleles as p.(Gly309*) and p.(Ser409*), against p.(Glu309*) and
p.(Ser419*) as given here and elsewhere. Neither discrepancy is resolvable
from the cached records, since the primary paper is abstract-only; take the
variant from the primary full text rather than from any review.
No missense allele has been reported, so there is no worked example of a
partial loss-of-function ODAD3 variant to reason from when a new missense
change turns up.
On the founder question, the two published opinions differ and neither is
conclusive. The recurrent c.925G>T allele appeared in two unrelated
Arabic-ancestry pedigrees, which is suggestive; the independent report of the
same allele found it absent from 238 controls and read that as arguing
against a founder effect. Absence from a small control panel shows the allele
is rare, which is not the same question - a founder allele can be rare. No
haplotype analysis has been published either way.
evidence:
- reference: PMID:25224326
reference_title: "Nonsense mutation in coiled-coil domain containing 151 gene (CCDC151) causes primary ciliary dyskinesia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The variant was absent in 238 randomly selected individuals indicating that
the variant is rare and likely not to be a founder mutation.
explanation: >-
The published argument against a founder effect, quoted so a reader can see
what it actually rests on.
- reference: PMID:33719352
reference_title: "Case Report: Identification of a Novel ODAD3 Variant in a Patient With Primary Ciliary Dyskinesia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We identified a novel homozygous variant in ODAD3, c.1166_1169dupAGAC,
p.(Leu391Aspfs*105) in the PCD patient by exome sequencing and Sanger
sequencing.
explanation: >-
One of the reported frameshift alleles.
- reference: PMID:32490514
reference_title: "Identification of a frame shift mutation in the CCDC151 gene in a Han-Chinese family with Kartagener syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In the present study, we identified a frame shift mutation, c.167delG
(p.G56Dfs*26), in the coiled-coil domain containing 151 gene (CCDC151)
responsible for KS in a Han-Chinese family.
explanation: >-
A further frameshift allele, reported under the CCDC151 symbol.
prevalence:
- population: Worldwide
measure_type: CASES_IN_LITERATURE
prevalence_class: ULTRA_RARE
notes: >-
Fewer than a dozen patients: five individuals from three families in the
defining series, plus single independently reported cases from Arabic,
mainland Chinese and Han-Chinese families. No ODAD3-specific prevalence
estimate exists, and none should be derived from the PCD population figure
(commonly quoted as roughly 1 in 10,000 to 1 in 20,000 live births) by
division, because the share of PCD attributable to any single one of the
fifty-odd known genes has not been established for ODAD3.
evidence:
- reference: PMID:25192045
reference_title: "CCDC151 mutations cause primary ciliary dyskinesia by disruption of the outer dynein arm docking complex formation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
we identified CCDC151 loss-of-function mutations in five affected
individuals from three independent families
explanation: >-
The defining series and its size.
- reference: PMID:33719352
reference_title: "Case Report: Identification of a Novel ODAD3 Variant in a Patient With Primary Ciliary Dyskinesia."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
The estimated prevalence of PCD is 1:10 000 to 1:20 000 live-born children
explanation: >-
The prevalence of the disease class, given for context. It is not this
entity's prevalence.
- reference: ORPHA:244
reference_title: "Primary ciliary dyskinesia"
supports: SUPPORT
evidence_source: OTHER
snippet: "1-9 / 100 000 | Europe | Prevalence at birth | PMID:23871404"
explanation: >-
Orphanet's birth-prevalence class for primary ciliary dyskinesia as a
whole. Recorded for context, and to make the point that Orphanet holds one
epidemiological record for the entire disease rather than per gene - the
same record that lists 53 causal genes including ODAD3.
animal_models:
- name: Ccdc151 knockout mouse (targeted gene deletion)
species: Mouse
genotype: Ccdc151 targeted deletion, homozygous null
publication: PMID:31383820
description: >-
A targeted-deletion mouse null for Ccdc151. It reproduces the laterality
defect and the male infertility of human ODAD3 disease, and adds a phenotype
the human disease does not have: perinatally lethal communicating
hydrocephalus. A beta-galactosidase reporter localises the gene's expression
to the ependymal cells lining the ventricular system, which explains the
hydrocephalus mechanistically - the ependymal motile cilia that drive
cerebrospinal fluid flow are the same machinery - without making it a human
finding.
modeled_mechanisms:
- target: Randomised Left-Right Body Asymmetry
relationship: RECAPITULATES
fidelity: HIGH
description: >-
Congenital left-right asymmetry defects occur in the null animals, matching
the human laterality phenotype and its nodal-cilia mechanism.
limitations: >-
Perinatal lethality means the model cannot be followed into the chronic
airway disease that dominates the human illness, so its usefulness is
confined to developmental phenotypes.
readouts:
- name: Left-right asymmetry in Ccdc151-null animals
target: Randomised Left-Right Body Asymmetry
direction: ALTERED
interpretation: >-
Presence of congenital laterality defects in the null, matching the human
phenotype.
evidence:
- reference: PMID:31383820
reference_title: "Functional loss of Ccdc151 leads to hydrocephalus in a mouse model of primary ciliary dyskinesia."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Congenital defects in left-right asymmetry and male infertility have
been also observed in Ccdc151-null animals.
explanation: >-
The laterality observation in the null mouse.
evidence:
- reference: PMID:31383820
reference_title: "Functional loss of Ccdc151 leads to hydrocephalus in a mouse model of primary ciliary dyskinesia."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
The CCDC151 gene encodes for a coiled-coil axonemal protein that ensures
correct attachment of outer dynein arm (ODA) complexes to microtubules.
explanation: >-
Establishes that the gene has the same molecular role across species,
which is what makes the model informative for this node. Graded OTHER
because it is background prose from the paper's introduction rather than
a result measured in the mouse.
- target: Motile Ciliary Beat Failure
relationship: PARTIALLY_RECAPITULATES
fidelity: MODERATE
description: >-
The null reproduces motile-cilia failure in the ependyma and the male
reproductive tract, but the tissue whose failure defines the human disease
- the conducting airway - cannot be assessed because the animals die
perinatally.
limitations: >-
Perinatal lethality from hydrocephalus prevents any study of chronic airway
disease, bronchiectasis, or the natural history that constitutes most of
the human illness. The dominant phenotype of the model is one the human
disease does not have; see the HUMAN_MODEL_MISMATCH discussion.
readouts:
- name: Sperm count and motility after adult Ccdc151 deletion
target: Motile Ciliary Beat Failure
direction: DECREASED
interpretation: >-
Deleting the gene in adults, which bypasses the perinatal lethality,
gives an isolated flagellar-motility readout of the same lesion.
evidence:
- reference: PMID:31383820
reference_title: "Functional loss of Ccdc151 leads to hydrocephalus in a mouse model of primary ciliary dyskinesia."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Ccdc151 gene deletion in adult animals results in abnormal sperm counts
and defective sperm motility.
explanation: >-
The adult-deletion motility measurement.
evidence:
- reference: PMID:31383820
reference_title: "Functional loss of Ccdc151 leads to hydrocephalus in a mouse model of primary ciliary dyskinesia."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Here, we demonstrate that loss of Ccdc151 gene function via targeted gene
deletion in mice leads to perinatal lethality and congenital
hydrocephalus.
explanation: >-
Graded PARTIAL because this is the limitation on the link as much as
support for it: the phenotype that dominates the model is not the
phenotype that dominates the disease.
- name: Odad3 conditional knockout mouse (adult male)
species: Mouse
genotype: Odad3 conditional deletion in adult males; and Odad3 heterozygous null
publication: PMID:38920681
description: >-
A conditional deletion that removes Odad3 in adult males and so escapes the
perinatal lethality of the constitutive null. It gives the only detailed
account of what ODAD3 loss does to a flagellum: asthenoteratozoospermia with
multiple morphological abnormalities of the sperm flagella, and
spermatogenesis arrested at the spermiogenesis and spermiation stages. The
same study reports a heterozygote effect - reduced sperm count and motility,
abnormal morphology, and a shorter fertile lifespan in Odad3+/- males - which
is a gene-dosage claim with no human counterpart and is the subject of an
open discussion below.
modeled_mechanisms:
- target: Motile Ciliary Beat Failure
relationship: RECAPITULATES
fidelity: MODERATE
description: >-
The sperm flagellum is a motile axoneme with the same outer dynein arm and
docking machinery as an airway cilium, so flagellar failure in this model is
the same lesion read out in a different cell. The model additionally shows
that Odad3 loss disrupts flagellar *morphogenesis*, not only motility.
limitations: >-
Fidelity is graded MODERATE, not HIGH, for two reasons. The readout is a
single motile cell type and not the multiciliated airway epithelium whose
failure defines the human disease. And the conditional deletion is imposed
on an adult animal whose spermatogenic machinery developed normally, which
is not the situation of a patient who has lacked ODAD3 since conception.
readouts:
- name: Sperm flagellar morphology and motility after adult Odad3 ablation
target: Motile Ciliary Beat Failure
direction: ALTERED
interpretation: >-
Multiple morphological abnormalities of the flagella with impaired
motility, in an axoneme built without ODAD3.
evidence:
- reference: PMID:38920681
reference_title: "The Odad3 Gene Is Necessary for Spermatozoa Development and Male Fertility in Mice."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
we conditionally deleted the Odad3 gene in adult males and demonstrated
that even partial ablation of the Odad3 gene leads to
asthenoteratozoospermia with multiple morphological abnormalities of
sperm flagella (MMAF) in mice
explanation: >-
The flagellar phenotype underlying this readout.
evidence:
- reference: PMID:38920681
reference_title: "The Odad3 Gene Is Necessary for Spermatozoa Development and Male Fertility in Mice."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Previously, we demonstrated that knockout of the Odad3 gene in mice
replicates several features of PCD, such as hydrocephalus, defects in
left-right body symmetry, and male infertility, with a complete absence
of sperm in the reproductive tract.
explanation: >-
Establishes the model lineage and which human features the mouse
reproduces, which is what makes it informative for this node.
- name: Ccdc151 morphant zebrafish
species: Zebrafish
genotype: ccdc151 morpholino knockdown; and homozygous ccdc151(ts272a)
publication: PMID:24067530
description: >-
The zebrafish work that identified CCDC151 as an outer-dynein-arm docking
protein before any human patient was known - it shares ancient features with
the outer dynein arm-docking complex 2 of Chlamydomonas. Depletion gives
left-right asymmetry defects and kidney cysts, and the motility defect was
localised to the two motile-ciliated structures that matter: Kupffer's
vesicle, the fish left-right organiser, and the pronephros.
modeled_mechanisms:
- target: Outer Dynein Arm Docking Complex Assembly Failure
relationship: RECAPITULATES
fidelity: MODERATE
description: >-
Ccdc151 depletion impairs motile ciliary function by controlling dynein arm
assembly, which is the same molecular step as the human lesion, established
in this species before the human disease existed.
limitations: >-
Morpholino knockdown is transient and incomplete rather than a null, and
the same study reports that vertebrate CCDC151 has acquired functions
beyond motility - a role in oriented cell division in the pronephros and in
the regulation of primary cilium length in mammalian cells. Those
additional functions are not part of the human PCD phenotype, so a
zebrafish phenotype cannot be assumed to be the motility phenotype.
readouts:
- name: Dynein arm assembly in Kupffer's vesicle and pronephric cilia
target: Outer Dynein Arm Docking Complex Assembly Failure
direction: DECREASED
interpretation: >-
Loss of motile function attributable to defective dynein arm assembly in
the two motile-ciliated organs assayed.
evidence:
- reference: PMID:24067530
reference_title: "The coiled-coil domain containing protein CCDC151 is required for the function of IFT-dependent motile cilia in animals."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
We demonstrate that Ccdc151 is required for proper motile function of
cilia in the Kupffer's vesicle and in the pronephros by controlling
dynein arm assembly
explanation: >-
The assembly measurement underlying this readout.
evidence:
- reference: PMID:24067530
reference_title: "The coiled-coil domain containing protein CCDC151 is required for the function of IFT-dependent motile cilia in animals."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
We identified a previously uncharacterized coiled-coil domain containing
protein CCDC151, which is evolutionarily conserved in motile ciliated
species and shares ancient features with the outer dynein arm-docking
complex 2 of Chlamydomonas.
explanation: >-
Establishes the protein's identity as a docking-complex component,
conserved from the alga that defined the structure.
diagnosis:
- name: Nasal Nitric Oxide Screening
description: >-
What happens before the electron microscope. Nasal nitric oxide is the
first-line screen for PCD, and it was very low in the reported ODAD3 patient
- 6 nl/min against a cut-off of 77. It is a triage test, not a diagnosis: it
selects who goes on to ultrastructural and genetic testing, and it neither
identifies the gene nor, on its own, confirms the disease.
evidence:
- reference: PMID:33719352
reference_title: "Case Report: Identification of a Novel ODAD3 Variant in a Patient With Primary Ciliary Dyskinesia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Her nasal nitric oxide concentration (nNO) (6 nl/min) was far below the
reference nNO cutoff value of PCD (77 nl/min)
explanation: >-
The screening result in the reported ODAD3 patient.
- name: Ultrastructural and Immunofluorescence Assessment of Outer Dynein Arms
description: >-
ODAD3 disease is one of the PCD forms that a diagnostic laboratory can
localise before sequencing. Electron microscopy shows outer dynein arms
missing with inner arms preserved, and immunofluorescence shows the
docking-complex members and the outer-arm heavy chain DNAH5 absent from the
axoneme. That pattern narrows the genetic differential to the ODA and
ODA-docking genes, which is a useful reduction from the fifty-odd PCD genes.
What it cannot do is name ODAD3. The docking complex fails as a unit, so a
defect in any of its members produces the same immunofluorescence picture -
which is why the diagnosis is completed by sequencing.
evidence:
- reference: PMID:25192045
reference_title: "CCDC151 mutations cause primary ciliary dyskinesia by disruption of the outer dynein arm docking complex formation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
cause a failure in axonemal assembly of the ODA component DNAH5 and the
ODA-DC-associated components CCDC114 and ARMC4
explanation: >-
The immunofluorescence pattern that identifies a docking-complex defect,
and the reason it cannot discriminate between the complex's members.
differential_diagnoses:
- name: Other outer dynein arm docking complex deficiencies (ODAD1, ODAD2, ODAD4)
description: >-
The closest differential, and the one that ultrastructure cannot resolve.
ODAD1 (CCDC114), ODAD2 (ARMC4) and ODAD4 (TTC25) are the other members of the
same complex, and defects in any of them give outer dynein arm loss with
randomised laterality. ODAD3 is distinguished from them only by sequencing.
Note that this knowledge base currently curates ODAD1 as a causal gene on the
umbrella `Primary Ciliary Dyskinesia` entry rather than as its own disease
entry, so a reader looking for its counterpart to this file will not find
one.
evidence:
- reference: PMID:27486780
reference_title: "TTC25 Deficiency Results in Defects of the Outer Dynein Arm Docking Machinery and Primary Ciliary Dyskinesia with Left-Right Body Asymmetry Randomization."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Additionally, IF analyses revealed an absence of the ODA docking complex
(ODA-DC), along with its known components CCDC114, CCDC151, and ARMC4.
explanation: >-
A different docking-complex gene's defect removes ODAD3 (CCDC151) from the
axoneme along with the rest of the complex - which is precisely why
immunofluorescence cannot discriminate ODAD3 disease from its siblings.
- name: Non-genetic causes of chronic suppurative airway disease
description: >-
The differential a clinician actually works through before any of the genetic
ones become relevant. A child with a chronic wet cough, recurrent infection
and bronchiectasis is far more likely to have cystic fibrosis, an antibody
deficiency or recurrent aspiration than a motile ciliopathy, and all three
were excluded in the reported Kartagener case before ciliary testing.
The feature that redirects the workup toward PCD is laterality: situs
inversus or heterotaxy belongs to none of these three, and its presence in a
patient with suppurative airway disease is close to diagnostic of a
motile-cilia disorder. Its absence excludes nothing, though - roughly half of
PCD patients have normal situs, and this disease's own MONDO term is
explicitly "with or without situs inversus".
evidence:
- reference: PMID:32490514
reference_title: "Identification of a frame shift mutation in the CCDC151 gene in a Han-Chinese family with Kartagener syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Cystic fibrosis, primary immunodeficiency diseases, and aspiration
pneumonia were excluded
explanation: >-
The exclusions performed in a reported CCDC151 patient before the ciliary
diagnosis was made.
- name: Outer dynein arm heavy-chain and dynein-preassembly deficiencies
description: >-
DNAH5 and other outer-arm components give outer dynein arm loss directly
rather than through a docking failure, and are clinically indistinguishable.
The dynein-preassembly factors are separable on ultrastructure, because they
remove inner arms as well as outer ones - which is exactly the distinction
that the HPO term chosen for the phenotype above preserves.
evidence:
- reference: PMID:25192045
reference_title: "CCDC151 mutations cause primary ciliary dyskinesia by disruption of the outer dynein arm docking complex formation."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
In humans, defects in ODA assembly are the major cause of primary ciliary
dyskinesia (PCD), an inherited disorder of ciliary and flagellar
dysmotility characterized by chronic upper and lower respiratory infections
and defects in laterality.
explanation: >-
Establishes that outer-arm assembly defects as a class are the largest
slice of the PCD differential.
discussions:
- discussion_id: pcd30_mouse_hydrocephalus_not_human
kind: HUMAN_MODEL_MISMATCH
status: OPEN
prompt: >-
Why is hydrocephalus the lethal phenotype of the Ccdc151-null mouse when
human ODAD3 patients survive to adulthood without it?
attaches_to:
- "pathophysiology#Motile Ciliary Beat Failure"
- "animal_models#Ccdc151 knockout mouse (targeted gene deletion)"
rationale: >-
Curated as HUMAN_MODEL_MISMATCH rather than KNOWLEDGE_GAP because the
evidence is not missing. The mouse phenotype is well characterised: targeted
deletion of Ccdc151 causes perinatal lethality and congenital communicating
hydrocephalus, with reporter expression localising the gene to the ependymal
cells lining the ventricular system and micro-computed tomography confirming
the aqueduct of Sylvius is patent. It is a coherent mechanism - ependymal
motile cilia drive cerebrospinal fluid flow, and they carry the same outer
dynein arms as airway cilia.
The mismatch is one of frequency and severity, and it should be stated
exactly rather than as a flat contradiction. Hydrocephalus is a recognised
possible complication of primary ciliary dyskinesia in humans - one of the
papers cited by this entry lists it among the consequences of ciliary
dysfunction in the brain and spinal ependyma, alongside conductive deafness
and subfertility. What is absent is any hydrocephalus in a reported *ODAD3*
patient: none of the five human ODAD3 reports consulted for this entry
describes it, and the individually described 35-year-old woman's reported
problems are sinusitis, bronchiectasis, dextrocardia and infertility. So the
consequence that is occasional and survivable in human PCD, and unreported in
this genotype, is in the mouse the phenotype that kills the animal before it
can develop the airway disease which defines the human illness.
Orphanet puts a number on the human side: hydrocephalus is graded Very rare,
under four percent, across primary ciliary dyskinesia as a class - against a
mouse null in which it is the cause of death. That is the mismatch stated
quantitatively rather than as an impression.
This is not peculiar to ODAD3 - hydrocephalus is a recurrent feature of mouse
motile-ciliopathy models and a rare one in human PCD. The usual explanation
offered for that gap is anatomical, that the rodent aqueduct is narrow and
rodent cerebrospinal-fluid circulation depends more on ependymal ciliary flow
than the human one does. That explanation is not tested by anything cited
here and is recorded as the standing hypothesis rather than as a finding. It
matters well beyond this gene, because it means a mouse motile-ciliopathy
model's most conspicuous phenotype may be its least transferable one.
The practical consequence for this entry: hydrocephalus is not curated as a
phenotype of PCD30, and the mouse link that carries it is graded
PARTIALLY_RECAPITULATES with the lethality stated as a limitation.
evidence:
- reference: PMID:32490514
reference_title: "Identification of a frame shift mutation in the CCDC151 gene in a Han-Chinese family with Kartagener syndrome."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
As cilia or flagella are also distributed in middle ear, sperm, fallopian
tube, brain, and spinal ependymal, KS may be accompanied by conductive
deafness, sub- or infertility, ectopic pregnancy, and hydrocephalus
explanation: >-
Graded PARTIAL because it cuts both ways: it establishes that
hydrocephalus is a recognised human PCD complication, which is why the
mismatch is one of frequency rather than of kind, while saying nothing
about any ODAD3 patient. Graded OTHER because it is a background statement
about Kartagener syndrome as a class within a case report.
- reference: ORPHA:244
reference_title: "Primary ciliary dyskinesia"
supports: SUPPORT
evidence_source: OTHER
snippet: "HP:0000238 | Hydrocephalus | Very rare (<4-1%)"
explanation: >-
Orphanet's graded frequency for hydrocephalus in primary ciliary
dyskinesia, which is what makes this a mismatch of frequency rather than
of kind: under four percent in humans as a class, against the lethal
phenotype of the mouse null. Graded PARTIAL for the same reason as the
item above - it establishes that hydrocephalus occurs in human PCD while
saying nothing about any ODAD3 patient.
proposed_experiments:
- experiment_id: exp_pcd30_human_ventricular_imaging
name: Systematic ventricular imaging in ODAD3 and other ODA-defect patients
description: >-
Measure ventricular volume and aqueductal patency in a genotyped PCD cohort
stratified by ultrastructural defect class, and ask whether subclinical
ventriculomegaly is present in humans at a frequency that routine care
would miss. A positive result would make the mouse phenotype a quantitative
rather than a qualitative mismatch.
- discussion_id: pcd30_heterozygote_fertility_effect
kind: OPEN_QUESTION
status: OPEN
prompt: >-
Do heterozygous ODAD3 carriers have reduced male fertility, as heterozygous
Odad3 mice do?
attaches_to:
- "animal_models#Odad3 conditional knockout mouse (adult male)"
- "genetic#ODAD3"
rationale: >-
A gene-dosage finding in the mouse with a direct counselling implication and
no human evidence either way.
Odad3 heterozygous null males have reduced sperm count and motility, abnormal
sperm morphology, and a shorter fertile lifespan. The authors state the
finding may bear on genetic and fertility counselling for carriers, which is
an unusually direct clinical suggestion from a mouse study.
Nobody has looked in humans. PCD carrier parents are ascertained routinely in
the course of diagnosing their children, so the cohort exists; semen analysis
in fathers of ODAD3 probands would answer the question directly and has never
been reported. Until it is, the recessive counselling given to ODAD3 families
should not be modified, and this entry curates no carrier phenotype - the
finding is recorded here so that a future carrier study is recognised as
testing a prediction rather than making an incidental observation.
One caution on how far to generalise it. The reduced fertile lifespan is an
age-dependent effect, and mouse and human reproductive ageing are on
different scales, so even a real human effect need not be detectable at the
ages at which carrier fathers are typically ascertained.
proposed_experiments:
- experiment_id: exp_pcd30_carrier_semen_analysis
name: Semen analysis in heterozygous ODAD3 carriers
description: >-
Compare sperm concentration, motility and morphology between confirmed
heterozygous ODAD3 carriers (fathers of probands) and age-matched
non-carrier controls, with stratification by age to test the
fertile-lifespan component of the mouse finding.
- discussion_id: pcd30_no_gene_specific_natural_history
kind: KNOWLEDGE_GAP
status: OPEN
prompt: >-
Does ODAD3 disease differ in course or treatment response from other forms of
PCD?
attaches_to:
- "pathophysiology#Bronchiectasis and Airway Wall Destruction"
- "phenotypes#Bronchiectasis"
rationale: >-
Curated as a genuine absence. There is no ODAD3-specific cohort, no lung
function trajectory, no survival data, and no treatment study. Everything
known about how to manage these patients comes from PCD as a class.
That is why this entry has no `treatments:` block and no `progression:`
block. Airway clearance, antibiotics and surveillance are the standard of
care for PCD and would certainly be given to an ODAD3 patient, but curating
them here would state that they have been studied in this genotype, which
they have not, and the exported graph would not preserve the difference.
The `Primary Ciliary Dyskinesia` umbrella entry carries the class-level
treatment content, and that is the right place for it.
Whether the distinction is worth drawing is itself open. Genotype-stratified
outcome data are beginning to appear for PCD, and the ODA-defect genes are
thought to sit at the more severe end. If that holds, ODAD3-specific
management guidance could eventually exist; if it does not, the class-level
content is all there will ever be.
proposed_experiments:
- experiment_id: exp_pcd30_genotype_stratified_outcomes
name: Genotype-stratified outcomes for docking-complex PCD
description: >-
Within an international PCD registry, compare lung-function trajectory,
exacerbation rate and age at bronchiectasis between patients with
docking-complex defects (ODAD1-4) and other ultrastructural classes, with
ODAD3 identified separately where numbers allow.
notes: >-
On the OMIM identifier. This disease is MIM 616037, CILD30, recorded
structurally in `external_assertions:` with the sentence that ties that number
to ODAD3 disease specifically. It is worth having explicitly because the
deep-research report committed with this entry cites the umbrella primary
ciliary dyskinesia number, 244400, instead; a reader comparing the two should
know which is right and that the entry knows it. Note that `mappings:` is not
the place for it - `DiseaseMappings` carries ICD-10-CM, ICD-11, MONDO and NCIT
only - and `external_assertions` is where OMIM disease records live in this
knowledge base.
On how the Orphanet frequency bands are used here, because they cut both ways
and were briefly applied inconsistently. The rule is: an ORPHA row supplies
`frequency:` where this entry has no gene-specific evidence bearing on it, and
is graded SUPPORT; where gene-specific evidence in this entry contradicts the
band, the gene-specific reading sets `frequency:` and the ORPHA row is graded
PARTIAL with the disagreement stated. So male infertility takes the class's
FREQUENT, because no ODAD3 male patient's fertility has been reported and the
band is all there is; bronchiectasis takes FREQUENT against the class's
Occasional, because both individually described ODAD3 patients have it; and
situs inversus totalis takes FREQUENT against the same band, because roughly
half of PCD patients have a laterality defect. An earlier revision let the
band raise male infertility while also letting it lower bronchiectasis below
what every described patient shows, which is the same rule applied in one
direction only. Both of the raised values match how the umbrella
`Primary Ciliary Dyskinesia` entry grades these identical Orphanet rows.
On neonatal respiratory distress, and a mistake worth recording rather than
quietly deleting. An earlier version of this block said the phenotype could not
be curated because it was not quotable, and that the only way to add it was
journal access to the 2014 paper. The premise was true - the defining paper's
cached record is `content_type: abstract_only` and its abstract does not carry
the finding - but the conclusion was wrong. Orphanet grades it, and
`references_cache/ORPHA_244.md` was already committed here and already cited by
this entry's `prevalence:` block. The phenotype is now curated from that row.
The reason this is written down is that it was the second instance of one
pattern in this entry: a section excluded on a confident claim about what the
repository could supply, where the premise was checked and the conclusion was
not. The first was the OMIM identifier, excluded from `mappings:` on the
correct observation that `DiseaseMappings` has no OMIM slot and the incorrect
inference that nothing else took one - `external_assertions` did, and 168
files already used it. Before writing that something cannot be curated, check
the caches this entry already cites.
On GeneReviews. PMID:20301301 ("Primary Ciliary Dyskinesia") is the applicable
chapter and is tagged in the top-level `references:` block. It is deliberately
not cited as evidence: its cached record carries only the chapter's statement
of purpose and no clinical content, so a snippet from it would attest to the
chapter's aims rather than to a fact about ODAD3 disease. It is also written at
the level of PCD as a class rather than of any gene.
Scope decision, recorded because the alternative was defensible. This entity
could have been curated as a `has_subtypes` entry on `Primary Ciliary
Dyskinesia`, which is where the knowledge base currently keeps ODAD1
(CCDC114) - the paralogous member of the very same docking complex, listed as a
causal gene in that entry's `genetic:` block. Curating ODAD3 as a separate
Disease therefore creates an asymmetry between two subunits of one structure,
and a reader is entitled to notice it. The right resolution is to promote
ODAD1 later, not to demote ODAD3, for a structural reason: the `Subtype` class
has no `pathophysiology`, no `phenotypes` and no `animal_models` slots, so a
subtype entry could not have carried the docking-complex causal chain, the
three model organisms, or the two discussions that make this entry worth
having. `Primary_Ciliary_Dyskinesia_47_and_Lissencephaly` is the existing
precedent for a numbered PCD form as a standalone entry.
The wider question this decision implicates, which one entry cannot settle.
There are 49 primary-ciliary-dyskinesia stubs in the curation queue and every
one is `entry_type: UNDECIDED`, so whatever shape this file takes is likely to
be copied dozens of times. Two things argue against copying it uncritically.
Orphanet does not split PCD by gene at all - `references_cache/ORPHA_244.md` is
a single disorder record listing 53 causal genes, ODAD3 among them - which is
an independent nosological signal against a file per gene. And the umbrella
entry's own `genotype_ultrastructure_severity` hypothesis already reasons along
a different axis entirely, grouping genotypes by ultrastructural defect class
rather than by OMIM number; a `has_subtypes` axis keyed on that class would
give all 49 stubs a home and give that hypothesis something structural to
attach to. This entry does not attempt that, because it is a class-level policy
decision rather than a per-disease one, and it should be made by a maintainer
with the whole queue in view. If the ruling goes that way, the content here
transfers: the pathograph and the animal models move to the umbrella's
ODA-defect subtype and nothing is lost but this file.
What this entry does not duplicate. The umbrella `Primary Ciliary Dyskinesia`
entry mentions ODAD3 already, in an animal-model block about Xenopus Lrrc56,
where axonemal Odad3 signal is used as the readout for a different gene's
defect. That is LRRC56 biology observed through ODAD3, not ODAD3 disease, and
it is not repeated here.
On the treatment and progression sections, which are absent. Airway clearance,
antibiotics and surveillance are the standard of care and would be given to any
of these patients, but no study has examined them in this genotype. Curating
them here would assert an evidence base that does not exist; the class-level
content lives on the umbrella entry and is correct there. The same reasoning
applies to lung-function decline rates and prevalence figures quoted for PCD as
a whole - the prevalence block cites one such figure and says explicitly that
it is the class's and not this entity's.
On hydrocephalus, which is also absent from the phenotypes. It is the dominant
phenotype of the mouse null and has no human ODAD3 counterpart. It is curated
where it belongs - on the mouse model link, with the lethality recorded as a
limitation - and argued out in a HUMAN_MODEL_MISMATCH discussion rather than
silently omitted.
Primary ciliary dyskinesia 30 (PCD30) is a very rare, autosomal-recessive motile ciliopathy caused by biallelic loss-of-function variants in ODAD3, historically named CCDC151. The defect prevents assembly of the outer dynein-arm docking machinery and outer dynein arms onto motile-ciliary axonemes. Respiratory cilia consequently beat very poorly, producing congenital mucociliary-clearance failure, recurrent sino-oto-pulmonary infection, and progressive bronchiectasis. Dysfunction of embryonic nodal cilia randomizes left–right development; four of the five individuals in the foundational series had a laterality defect. Human gene-specific knowledge remains based principally on five affected individuals from three families, supplemented by one independently reported Arabic case and strong mouse, zebrafish, and other comparative evidence. Most natural-history, prognosis, and treatment statements below therefore derive from PCD overall, not specifically PCD30. (hjeij2014ccdc151mutationscause pages 1-2, hjeij2014ccdc151mutationscause pages 2-3, alsaadi2014nonsensemutationin pages 1-2)
| domain | finding | quantitative detail | evidence type/source |
|---|---|---|---|
| Disease identity | ODAD3/CCDC151-related primary ciliary dyskinesia corresponds to a gene-specific form of PCD; ODAD3 is the current HGNC-approved symbol for the former CCDC151 gene product name “outer dynein arm docking complex subunit 3” | Open Targets links ODAD3 to primary ciliary dyskinesia; historical literature uses CCDC151 | Curated disease-target association plus primary human gene-discovery paper (OpenTargets Search: Primary ciliary dyskinesia-ODAD3,CCDC151, hjeij2014ccdc151mutationscause pages 1-2) |
| Inheritance | Inheritance is autosomal recessive | Segregation consistent with recessive disease in reported families | Human clinical genetics/segregation study (hjeij2014ccdc151mutationscause pages 2-3, alsaadi2014nonsensemutationin pages 1-2) |
| Causal variants | Two recurrent truncating variants were identified in the foundational series | c.925G>T (p.Glu309) and c.1256C>A (p.Ser419); both absent from 1000 Genomes and EVS in the 2014 report | Human NGS/exome plus Sanger confirmation (hjeij2014ccdc151mutationscause pages 2-3) |
| Reported patients/families | Foundational disease-specific evidence base is very small | 5 affected individuals from 3 unrelated families | Human case series/gene-discovery study (hjeij2014ccdc151mutationscause pages 1-2, hjeij2014ccdc151mutationscause pages 2-3) |
| Core respiratory phenotype | All reported affected individuals had a phenotype consistent with PCD | Recurrent upper and lower airway disease, chronic respiratory symptoms, bronchiectasis, nasal blockage/polyps, otitis media reported across the 5-person series | Human clinical case series (hjeij2014ccdc151mutationscause pages 2-3) |
| Neonatal onset | Early presentation is typical in the reported gene-specific cases | 4/5 had very early involvement with neonatal respiratory distress syndrome | Human clinical case series (hjeij2014ccdc151mutationscause pages 2-3) |
| Laterality phenotype | Laterality defects are common in this gene-specific form | 4/5 had laterality defects; one had congenital heart disease (ventricular septal defect) | Human clinical case series (hjeij2014ccdc151mutationscause pages 2-3) |
| Ultrastructure | Hallmark ciliary defect is isolated outer dynein arm loss | Respiratory cilia showed complete ODA loss and specific loss of ODAs on TEM | Human TEM plus conserved model-organism data (hjeij2014ccdc151mutationscause pages 1-2, hjeij2014ccdc151mutationscause pages 11-15) |
| Protein localization defect | ODAD3/CCDC151 loss disrupts axonemal assembly of ODA machinery | CCDC151 severely reduced or absent from axonemes; axonemal DNAH5, CCDC114, and ARMC4 fail to localize properly | Human immunofluorescence and protein-interaction data (hjeij2014ccdc151mutationscause pages 1-2, hjeij2014ccdc151mutationscause pages 15-16) |
| Mechanism | Disease mechanism is failure of outer dynein arm docking-complex formation | CCDC151 interacts with CCDC114 and is required for assembly of ODA docking components and ODAs onto axonemes | Human co-immunoprecipitation, IF, TEM; mouse/zebrafish corroboration (hjeij2014ccdc151mutationscause pages 1-2, hjeij2014ccdc151mutationscause pages 15-16) |
| Ciliary function | Ciliary beating is severely impaired because ODA force-generating machinery is lost | Report described severely impaired ciliary beating or dysmotility associated with ODA deficiency | Human respiratory cilia studies with animal corroboration (hjeij2014ccdc151mutationscause pages 1-2) |
| Model-organism support | Conservation across species strongly supports causality | CCDC151-deficient zebrafish and mouse show ciliary dysmotility, situs defects, and complex heart defects; prior work also cites Chlamydomonas and Drosophila relevance | Model-organism evidence integrated with human genetics (hjeij2014ccdc151mutationscause pages 1-2, hjeij2014ccdc151mutationscause pages 11-15) |
| General PCD epidemiology (extrapolated, not CCDC151-specific) | PCD is rare and underdiagnosed | Approximate prevalence cited as ~1 in 10,000 in iPCD cohort background; other reviews cite 1:15,000 to 30,000 | Large disease-level cohort/review; extrapolated to this subtype with caution (goutaki2017theinternationalprimary pages 2-3, paff2021currentandfuture pages 1-2) |
| General PCD laterality (extrapolated, not CCDC151-specific) | Laterality defects occur in about half of all PCD cases overall | Around 50% with laterality defects; about 12% may have heterotaxy or complex isomerism in general PCD literature | Disease-level review/background; extrapolated only (hjeij2014ccdc151mutationscause pages 2-3, paff2021currentandfuture pages 1-2) |
| General PCD lung burden (extrapolated, not CCDC151-specific) | Lung disease begins early and can be progressive | In iPCD, children 6–9 years had mean FEV1 z-score -0.84; review cites average FEV1 decline about 0.8% per year | International cohort and review; not subtype-specific (halbeisen2018lungfunctionin pages 2-3, paff2021currentandfuture pages 1-2) |
| Evidence limitation | Natural history, prevalence, prognosis, and treatment-response data specific to ODAD3/CCDC151 are not yet established | No robust 2023–2024 gene-specific cohorts identified; most management is inferred from general PCD practice | Evidence-gap statement based on available literature set (hjeij2014ccdc151mutationscause pages 1-2, goutaki2017theinternationalprimary pages 2-3, paff2021currentandfuture pages 1-2) |
Table: This table summarizes the core disease-specific evidence for ODAD3/CCDC151-related PCD30 and distinguishes it from broader primary ciliary dyskinesia data. It is useful for quickly separating directly observed subtype facts from extrapolated general PCD knowledge.
PCD30 is a congenital disorder of motile cilia in which ODAD3 deficiency causes isolated outer dynein-arm (ODA) loss and severe ciliary dysmotility. It belongs to the respiratory ciliopathies and clinically manifests as lifelong wet cough, chronic rhinosinusitis, recurrent lower-respiratory infection, otitis media, bronchiectasis, laterality abnormalities, and probable sex-specific fertility impairment. The foundational paper describes PCD generally as producing “lifelong recurrent respiratory infections and irreversible, destructive airway disease (bronchiectasis) of early onset.” (hjeij2014ccdc151mutationscause pages 2-3)
The evidence is aggregated disease-level literature and family-based research, not an individual EHR extract.
PCD30 is caused by germline biallelic ODAD3 loss of function. Familial segregation in the discovery families was consistent with autosomal-recessive inheritance. The initial variants were absent from the 1000 Genomes and NHLBI Exome Variant Server datasets available in 2014. (hjeij2014ccdc151mutationscause pages 2-3)
The principal risk factors are carrier parents, an affected sibling, shared ancestry, and consanguinity. Consanguinity facilitated homozygosity mapping in the reported Bedouin-Arabic and UK-Pakistani families. No environmental exposure causes the genetic disease, and no validated susceptibility loci, modifier genes, protective alleles, epigenetic modifiers, or gene–environment interactions are established specifically for ODAD3-related PCD.
Environmental factors instead modify downstream morbidity. Tobacco smoke, vaping, particulate pollution, poor infection control, and delayed antimicrobial treatment plausibly increase respiratory injury; vaccination, smoke avoidance, exercise, airway clearance, and early treatment may reduce complications but do not prevent the underlying ciliopathy. These are expert-practice extrapolations from PCD/bronchiectasis, not ODAD3-specific intervention evidence. PCD treatment evidence remains sparse: a review found only three randomized trials and noted that practice is largely based on expert opinion and cystic-fibrosis extrapolation. (paff2021currentandfuture pages 1-2)
All five individuals in the foundational series had recurrent upper- and lower-airway disease, chronic respiratory symptoms and bronchiectasis, with nasal obstruction/polyps and otitis media. Four of five had neonatal respiratory distress and four of five had a laterality defect; one had a ventricular septal defect. (hjeij2014ccdc151mutationscause pages 2-3)
Suggested phenotype annotations are:
Percentages such as 80% neonatal distress or laterality must be treated as descriptive fractions, not stable prevalence estimates, because the denominator is only five and ascertainment favored ODA-deficient PCD.
Approximately half of people with PCD have situs inversus or another laterality defect; broad PCD literature estimates complex heterotaxy/isomerism in about 12%. (paff2021currentandfuture pages 1-2, hjeij2014ccdc151mutationscause pages 2-3) In an international study of 991 patients, lung function was impaired in both sexes and every age group. Children aged 6–9 years had mean FEV1 z-score −0.84 and FVC z-score −0.31; mean FEV1 was 91% predicted at 6–9 years and 79% at 18–21 years. These values demonstrate early disease but are not ODAD3-specific. (halbeisen2018lungfunctionin pages 2-3)
Upper-airway disease materially affects well-being. A 2023 genetically confirmed PCD cohort of 58 found chronic rhinosinusitis in all participants, prior sinus surgery in 47%, mean SNOT-20 score 35.8±17, and mean Lund–Mackay CT score 10.2±4.4; frontal- and sphenoid-sinus agenesis occurred in 19% and 9.5% of participants aged at least 16. These findings should not be assigned specifically to ODAD3 without genotype-level data.
The foundational study identified five patients from three families with homozygous nonsense alleles:
An independent consanguineous Arabic case carried homozygous c.925G>T, had bronchiectasis, recurrent chest infections, chronic productive cough, very low nasal nitric oxide, asthma/allergic rhinitis and pectus excavatum; the allele was absent from 238 controls. (alsaadi2014nonsensemutationin pages 1-2)
These are truncating, germline, recessive loss-of-function variants. Contemporary clinical classification should use ACMG/AMP criteria, current transcript normalization, segregation, phenotype, population frequency, and functional evidence. No somatic mechanism, repeat expansion, mitochondrial defect, recurrent chromosomal rearrangement, or aneuploidy is implicated. Large deletions or noncoding ODAD3 alleles remain possible and justify deletion/duplication analysis or genome sequencing in unresolved cases.
ODAD3 encodes a 595-amino-acid, highly conserved protein with three predicted coiled-coil domains. The two reported truncations lie within coiled-coil regions and are predicted to disrupt protein interactions. No validated ODAD3-specific modifier gene or disease-associated methylation signature is known. (hjeij2014ccdc151mutationscause pages 2-3)
Bacteria and viruses are complications or exacerbation triggers, not causes. Impaired clearance permits chronic/recurrent airway infection and a mucus–infection–inflammation cycle. Pathogens encountered in PCD/bronchiectasis commonly include Haemophilus influenzae, Staphylococcus aureus, Streptococcus pneumoniae, and later Pseudomonas aeruginosa; organism-specific frequencies are unavailable for ODAD3.
Avoidance of tobacco smoke, vaping, biomass smoke, occupational dusts, and excessive air pollution is prudent. Regular physical activity and hydration may support airway clearance. No diet, supplement, alcohol pattern, toxin, radiation exposure, or infectious agent has been shown to alter penetrance of ODAD3 deficiency.
Biallelic ODAD3 loss of function → absent/truncated ODAD3 in the axoneme → failure to assemble ODAD docking proteins CCDC114/ODAD1 and ARMC4/ODAD2 → failure to localize DNAH5-containing outer dynein arms → loss of most axonemal sliding force → severely dyskinetic or static motile cilia → impaired mucociliary transport → mucus retention, infection and neutrophilic inflammation → airway-wall injury and bronchiectasis. In embryonic left–right organizers, defective nodal flow randomizes organ laterality and may produce heterotaxy/congenital heart disease. (hjeij2014ccdc151mutationscause pages 1-2, hjeij2014ccdc151mutationscause pages 15-16, hjeij2014ccdc151mutationscause pages 2-3)
ODAs occur at approximately 24-nm intervals along axonemal microtubules and generate as much as four-fifths of the sliding force required for ciliary bending. Thus ODA loss explains the severe motility phenotype. (hjeij2014ccdc151mutationscause pages 2-3)
Human respiratory-cell immunofluorescence showed absent axonemal CCDC114, ARMC4 and DNAH5, while inner-dynein-arm markers remained preserved. Co-immunoprecipitation demonstrated reciprocal association between ODAD3/CCDC151 and CCDC114. TEM showed complete ODA loss. These human cellular results provide direct evidence rather than computational inference. (hjeij2014ccdc151mutationscause pages 1-2, hjeij2014ccdc151mutationscause pages 11-15, hjeij2014ccdc151mutationscause pages 15-16)
No ODAD3-specific transcriptomic, proteomic, metabolomic, lipidomic, single-cell, spatial-transcriptomic, or multi-omic patient signature has been established. The decisive profiling methods remain targeted immunofluorescence, TEM, high-speed videomicroscopy, and genomic sequencing.
Primary sites are multiciliated epithelia of the nose, paranasal sinuses, middle ear/Eustachian tube, trachea and bronchi; embryonic left–right organizers; and reproductive-tract motile cilia/flagella. Secondary damage includes bronchiectasis, mucus plugging, atelectasis, chronic sinus opacification, conductive hearing impairment, and occasionally respiratory failure.
Suggested anatomy terms include UBERON:0001004 respiratory system, UBERON:0002048 lung, UBERON:0003126 trachea, UBERON:0002185 bronchus, UBERON:0000004 nose, UBERON:0001825 paranasal sinus, UBERON:0001756 middle ear, and reproductive tract structures. The relevant subcellular structure is the apical 9+2 motile-ciliary axoneme. Laterality may be normal, completely reversed, or heterotaxic; respiratory disease is generally bilateral/diffuse rather than unilateral.
The molecular defect is congenital. Four of five foundational patients had neonatal respiratory distress; persistent wet cough, nasal congestion and recurrent infection begin in infancy or childhood. Bronchiectasis is an acquired but often early and progressive complication. Laterality and congenital cardiac defects arise during embryogenesis and do not progress. (hjeij2014ccdc151mutationscause pages 2-3)
PCD is lifelong, with fluctuating infectious exacerbations superimposed on chronic disease. Broad PCD estimates suggest average FEV1 decline near 0.8 percentage points annually, but trajectories vary and this rate is not ODAD3-specific. (paff2021currentandfuture pages 1-2) There is no spontaneous molecular remission. Early diagnosis, daily clearance, infection control, hearing surveillance and nutritional support represent the main windows for preventing irreversible damage.
Inheritance is autosomal recessive. For two carrier parents, each pregnancy has a 25% probability of an affected child, 50% probability of an unaffected carrier, and 25% probability of inheriting neither familial allele. Penetrance of biallelic truncating variants appears high, but the available families are too few to estimate it. Expressivity is variable, particularly for laterality; anticipation is not expected. Germline mosaicism has not been specifically reported but cannot be excluded.
Broad PCD prevalence is often estimated around 1:10,000, with reviews citing approximately 1:15,000–30,000 and substantial underdiagnosis. ODAD3-specific prevalence and incidence are unknown. (goutaki2017theinternationalprimary pages 2-3, paff2021currentandfuture pages 1-2) In the 3,013-person iPCD cohort, 49% were male, ages ranged from 0–92 years, median age was 18, and 38% were aged 10–19. This near-equal sex distribution is consistent with autosomal inheritance. (goutaki2017theinternationalprimary pages 6-7)
The recurrent c.925G>T allele occurred in two Arabic-origin pedigrees. The original investigators could not exclude a founder effect because haplotypes were unavailable, whereas the independent report considered a founder effect unlikely after absence in 238 controls. These interpretations are not definitive. (hjeij2014ccdc151mutationscause pages 15-16, alsaadi2014nonsensemutationin pages 1-2)
Suspect PCD in term neonates with unexplained respiratory distress, persistent year-round wet cough or nasal congestion beginning before six months, recurrent otitis/hearing problems, bronchiectasis without another cause, or any such phenotype combined with situs abnormality. PICADAR may support referral but cannot confirm disease.
No single negative test excludes all PCD. Expert assessment combines:
The foundational families were solved through targeted NGS, WES, autozygosity mapping, segregation testing and Sanger confirmation. (hjeij2014ccdc151mutationscause pages 2-3) A 2024 WGS study found pathogenic/likely pathogenic biallelic diagnoses in 7/8 selected PCD cases and resolved 3–13-kb deletions; it estimated that standard testing currently solves about 70% of PCD and argued that WGS can identify structural, noncoding, and novel-gene mechanisms. These figures concern PCD generally, not ODAD3.
CMA, karyotyping and FISH are not first-line tests for isolated PCD30; mitochondrial and repeat-expansion testing are not indicated. RNA studies may clarify splice or noncoding variants but are not routine diagnostic biomarkers. Carrier and cascade testing should target confirmed familial variants.
Important alternatives are cystic fibrosis, immunodeficiency, aspiration/swallowing dysfunction, post-infectious bronchiectasis, allergic bronchopulmonary aspergillosis, severe asthma, congenital airway malformation, Young syndrome, alpha-1 antitrypsin deficiency, and acquired secondary ciliary injury. CF is distinguished by sweat chloride/CFTR testing; immune disease by quantitative immunoglobulins and vaccine responses; secondary dyskinesia should improve on repeat/cultured sampling. Kartagener syndrome denotes the PCD-plus-situs-inversus phenotype rather than a separate mechanism.
No ODAD3-specific survival curve, mortality rate, life expectancy, transplant-free survival, or validated prognostic biomarker exists. Broad PCD can progress from chronic infection to bronchiectasis, airflow obstruction, chronic Pseudomonas infection, oxygen dependence, respiratory failure and lung transplantation. The iPCD investigators explicitly noted that age-standardized mortality data were unavailable and that genotype effects on mortality remained unclear. (goutaki2017theinternationalprimary pages 2-3)
Disease severity is not necessarily mild. In general PCD, FEV1 is already reduced in early school age and can approximate cystic-fibrosis impairment during childhood. (halbeisen2018lungfunctionin pages 2-3) Potential adverse prognostic factors include delayed diagnosis, low baseline FEV1, poor nutritional status, frequent exacerbations, chronic Pseudomonas, inadequate airway clearance and extensive bronchiectasis. Unlike CCDC39/CCDC40-associated microtubular disorganization, ODAD3 has not been proven to define an especially aggressive lung-function trajectory.
Quality of life is impaired by daily treatment burden, cough, sputum, sinus symptoms, hearing difficulty, fatigue, school/work disruption and fertility concerns. Valid tools include QOL-PCD, SNOT-20/22, spirometry and exacerbation frequency; no ODAD3-specific patient-reported measure exists.
There is no approved ODAD3-restoring or curative therapy. Management should occur in a specialist multidisciplinary PCD/bronchiectasis center.
The evidence base is modest: current treatment primarily seeks “improving mucociliary clearance and early treatment of bacterial airway infections,” and no causal treatment was available in the reviewed clinical literature. (paff2021currentandfuture pages 1-2)
mRNA replacement, gene addition/editing, read-through therapy and airway epithelial correction are rational strategies, but none has established clinical efficacy for ODAD3. Trials retrieved for PCD overall included phase-1 inhaled mRNA program RCT1100 (NCT05737485, completed; NCT06600425, completed), ENaC inhibition (NCT02871778, phase 2, 123 participants, completed), diagnostic-care utility (NCT03704207, recruiting), and airway-clearance/physiotherapy studies. These are not ODAD3-specific and trial status should be rechecked at https://clinicaltrials.gov before use. No genotype-guided pharmacogenomic recommendation exists.
Primary prevention of an affected conception is possible only through informed reproductive options: carrier testing, partner testing, prenatal diagnosis, and preimplantation genetic testing for a known familial variant. There is no newborn population screen for PCD30.
Secondary prevention consists of early recognition, cascade testing of relatives, and prompt specialist referral. Tertiary prevention includes daily airway clearance, respiratory cultures, timely antibiotics, routine spirometry, nutrition and hearing monitoring, influenza and COVID-19 immunization, age-appropriate pneumococcal vaccination, smoke avoidance, exercise, and hygiene measures. Vaccines prevent infectious complications, not ODAD3 deficiency.
Genetic counseling should explain recessive recurrence risks, uncertainty in phenotype prediction, variable organ laterality, fertility implications, and the possibility that a VUS is not diagnostic without segregation and functional evidence.
ODAD3/CCDC151 function is evolutionarily conserved in motile cilia. Orthologous defects have been studied in mouse (Mus musculus, NCBI Taxon 10090), zebrafish (Danio rerio, 7955), fruit fly (Drosophila melanogaster, 7227), green alga Chlamydomonas reinhardtii (3055), and planarian systems. The 2014 study concluded from human cells, mice and zebrafish that CCDC151 is required for ODA/docking-complex assembly and correct left–right patterning. (hjeij2014ccdc151mutationscause pages 1-2, hjeij2014ccdc151mutationscause pages 11-15)
No established naturally occurring veterinary ODAD3 syndrome, breed predisposition, VBO annotation, or animal-health prevalence was identified. The condition is inherited and noninfectious, with no zoonotic or cross-species transmission.
Recent advances mostly concern PCD broadly rather than new ODAD3 cohorts: a 2024 state-of-the-art pediatric review emphasized underdiagnosis, expanded phenotypes, genotype–phenotype relationships and emerging therapeutics; 2024 WGS work demonstrated improved detection of structural and noncoding mechanisms; and 2023 imaging studies quantified substantial sinonasal structural disease and quality-of-life burden. Nevertheless, no 2023–2024 study established ODAD3-specific prevalence, longitudinal decline, treatment response, single-cell profile, or targeted therapy. The foundational ODAD3 evidence therefore remains Hjeij et al., published 4 September 2014, DOI https://doi.org/10.1016/j.ajhg.2014.08.005, PMID 25192045. (OpenTargets Search: Primary ciliary dyskinesia-ODAD3,CCDC151, hjeij2014ccdc151mutationscause pages 1-2, hjeij2014ccdc151mutationscause pages 15-16)
Overall, ODAD3-related PCD30 is a well-supported molecular diagnosis with a clear ODA-docking mechanism, but its disease-specific epidemiology and natural history remain severely underpowered. Knowledge-base assertions should retain provenance labels—human ODAD3-specific, model-organism, or general-PCD extrapolation—rather than treating all PCD statistics as subtype-specific.
References
(hjeij2014ccdc151mutationscause pages 1-2): Rim Hjeij, Alexandros Onoufriadis, Christopher M. Watson, Christopher E. Slagle, Nikolai T. Klena, Gerard W. Dougherty, Małgorzata Kurkowiak, Niki T. Loges, Christine P. Diggle, Nicholas F.C. Morante, George C. Gabriel, Kristi L. Lemke, You Li, Petra Pennekamp, Tabea Menchen, Franziska Konert, June Kehlet Marthin, Dorus A. Mans, Stef J.F. Letteboer, Claudius Werner, Thomas Burgoyne, Cordula Westermann, Andrew Rutman, Ian M. Carr, Christopher O’Callaghan, Eduardo Moya, Eddie M.K. Chung, Eamonn Sheridan, Kim G. Nielsen, Ronald Roepman, Kerstin Bartscherer, Rebecca D. Burdine, Cecilia W. Lo, Heymut Omran, and Hannah M. Mitchison. Ccdc151 mutations cause primary ciliary dyskinesia by disruption of the outer dynein arm docking complex formation. American Journal of Human Genetics, 95:257-274, Sep 2014. URL: https://doi.org/10.1016/j.ajhg.2014.08.005, doi:10.1016/j.ajhg.2014.08.005. This article has 209 citations and is from a highest quality peer-reviewed journal.
(hjeij2014ccdc151mutationscause pages 2-3): Rim Hjeij, Alexandros Onoufriadis, Christopher M. Watson, Christopher E. Slagle, Nikolai T. Klena, Gerard W. Dougherty, Małgorzata Kurkowiak, Niki T. Loges, Christine P. Diggle, Nicholas F.C. Morante, George C. Gabriel, Kristi L. Lemke, You Li, Petra Pennekamp, Tabea Menchen, Franziska Konert, June Kehlet Marthin, Dorus A. Mans, Stef J.F. Letteboer, Claudius Werner, Thomas Burgoyne, Cordula Westermann, Andrew Rutman, Ian M. Carr, Christopher O’Callaghan, Eduardo Moya, Eddie M.K. Chung, Eamonn Sheridan, Kim G. Nielsen, Ronald Roepman, Kerstin Bartscherer, Rebecca D. Burdine, Cecilia W. Lo, Heymut Omran, and Hannah M. Mitchison. Ccdc151 mutations cause primary ciliary dyskinesia by disruption of the outer dynein arm docking complex formation. American Journal of Human Genetics, 95:257-274, Sep 2014. URL: https://doi.org/10.1016/j.ajhg.2014.08.005, doi:10.1016/j.ajhg.2014.08.005. This article has 209 citations and is from a highest quality peer-reviewed journal.
(alsaadi2014nonsensemutationin pages 1-2): Muslim M. Alsaadi, A. Mesut Erzurumluoglu, Santiago Rodriguez, Philip A. I. Guthrie, Tom R. Gaunt, Hager Z. Omar, Mohammad Mubarak, Khalid K. Alharbi, Ammar C. Al-Rikabi, and Ian N. M. Day. Nonsense mutation in coiled-coil domain containing 151 gene (ccdc151) causes primary ciliary dyskinesia. Nov 2014. URL: https://doi.org/10.1002/humu.22698, doi:10.1002/humu.22698. This article has 47 citations and is from a domain leading peer-reviewed journal.
(OpenTargets Search: Primary ciliary dyskinesia-ODAD3,CCDC151): Open Targets Query (Primary ciliary dyskinesia-ODAD3,CCDC151, 3 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.
(hjeij2014ccdc151mutationscause pages 11-15): Rim Hjeij, Alexandros Onoufriadis, Christopher M. Watson, Christopher E. Slagle, Nikolai T. Klena, Gerard W. Dougherty, Małgorzata Kurkowiak, Niki T. Loges, Christine P. Diggle, Nicholas F.C. Morante, George C. Gabriel, Kristi L. Lemke, You Li, Petra Pennekamp, Tabea Menchen, Franziska Konert, June Kehlet Marthin, Dorus A. Mans, Stef J.F. Letteboer, Claudius Werner, Thomas Burgoyne, Cordula Westermann, Andrew Rutman, Ian M. Carr, Christopher O’Callaghan, Eduardo Moya, Eddie M.K. Chung, Eamonn Sheridan, Kim G. Nielsen, Ronald Roepman, Kerstin Bartscherer, Rebecca D. Burdine, Cecilia W. Lo, Heymut Omran, and Hannah M. Mitchison. Ccdc151 mutations cause primary ciliary dyskinesia by disruption of the outer dynein arm docking complex formation. American Journal of Human Genetics, 95:257-274, Sep 2014. URL: https://doi.org/10.1016/j.ajhg.2014.08.005, doi:10.1016/j.ajhg.2014.08.005. This article has 209 citations and is from a highest quality peer-reviewed journal.
(hjeij2014ccdc151mutationscause pages 15-16): Rim Hjeij, Alexandros Onoufriadis, Christopher M. Watson, Christopher E. Slagle, Nikolai T. Klena, Gerard W. Dougherty, Małgorzata Kurkowiak, Niki T. Loges, Christine P. Diggle, Nicholas F.C. Morante, George C. Gabriel, Kristi L. Lemke, You Li, Petra Pennekamp, Tabea Menchen, Franziska Konert, June Kehlet Marthin, Dorus A. Mans, Stef J.F. Letteboer, Claudius Werner, Thomas Burgoyne, Cordula Westermann, Andrew Rutman, Ian M. Carr, Christopher O’Callaghan, Eduardo Moya, Eddie M.K. Chung, Eamonn Sheridan, Kim G. Nielsen, Ronald Roepman, Kerstin Bartscherer, Rebecca D. Burdine, Cecilia W. Lo, Heymut Omran, and Hannah M. Mitchison. Ccdc151 mutations cause primary ciliary dyskinesia by disruption of the outer dynein arm docking complex formation. American Journal of Human Genetics, 95:257-274, Sep 2014. URL: https://doi.org/10.1016/j.ajhg.2014.08.005, doi:10.1016/j.ajhg.2014.08.005. This article has 209 citations and is from a highest quality peer-reviewed journal.
(goutaki2017theinternationalprimary pages 2-3): M. Goutaki, Elisabeth Maurer, F. Halbeisen, I. Amirav, A. Barbato, L. Behan, M. Boon, C. Casaulta, A. Clément, S. Crowley, E. Haarman, C. Hogg, B. Karadag, C. Koerner-Rettberg, M. Leigh, M. Loebinger, H. Mazurek, L. Morgan, K. Nielsen, H. Omran, N. Schwerk, S. Scigliano, C. Werner, P. Yiallouros, Z. Zivković, J. Lucas, and C. Kuehni. The international primary ciliary dyskinesia cohort (ipcd cohort): methods and first results. The European Respiratory Journal, Jan 2017. URL: https://doi.org/10.1183/13993003.01181-2016, doi:10.1183/13993003.01181-2016. This article has 81 citations.
(paff2021currentandfuture pages 1-2): Tamara Paff, Heymut Omran, Kim G. Nielsen, and Eric G. Haarman. Current and future treatments in primary ciliary dyskinesia. Sep 2021. URL: https://doi.org/10.3390/ijms22189834, doi:10.3390/ijms22189834. This article has 150 citations.
(halbeisen2018lungfunctionin pages 2-3): Florian S. Halbeisen, Myrofora Goutaki, Ben D. Spycher, Israel Amirav, Laura Behan, Mieke Boon, Claire Hogg, Carmen Casaulta, Suzanne Crowley, Eric G. Haarman, Bulent Karadag, Cordula Koerner-Rettberg, Michael R. Loebinger, Henryk Mazurek, Lucy Morgan, Kim G. Nielsen, Heymut Omran, Francesca Santamaria, Nicolaus Schwerk, Guillaume Thouvenin, Panayiotis Yiallouros, Jane S. Lucas, Philipp Latzin, and Claudia E. Kuehni. Lung function in patients with primary ciliary dyskinesia: an ipcd cohort study. European Respiratory Journal, 52:1801040, Jul 2018. URL: https://doi.org/10.1183/13993003.01040-2018, doi:10.1183/13993003.01040-2018. This article has 128 citations and is from a highest quality peer-reviewed journal.
(goutaki2017theinternationalprimary pages 6-7): M. Goutaki, Elisabeth Maurer, F. Halbeisen, I. Amirav, A. Barbato, L. Behan, M. Boon, C. Casaulta, A. Clément, S. Crowley, E. Haarman, C. Hogg, B. Karadag, C. Koerner-Rettberg, M. Leigh, M. Loebinger, H. Mazurek, L. Morgan, K. Nielsen, H. Omran, N. Schwerk, S. Scigliano, C. Werner, P. Yiallouros, Z. Zivković, J. Lucas, and C. Kuehni. The international primary ciliary dyskinesia cohort (ipcd cohort): methods and first results. The European Respiratory Journal, Jan 2017. URL: https://doi.org/10.1183/13993003.01181-2016, doi:10.1183/13993003.01181-2016. This article has 81 citations.
(hjeij2014ccdc151mutationscause pages 3-4): Rim Hjeij, Alexandros Onoufriadis, Christopher M. Watson, Christopher E. Slagle, Nikolai T. Klena, Gerard W. Dougherty, Małgorzata Kurkowiak, Niki T. Loges, Christine P. Diggle, Nicholas F.C. Morante, George C. Gabriel, Kristi L. Lemke, You Li, Petra Pennekamp, Tabea Menchen, Franziska Konert, June Kehlet Marthin, Dorus A. Mans, Stef J.F. Letteboer, Claudius Werner, Thomas Burgoyne, Cordula Westermann, Andrew Rutman, Ian M. Carr, Christopher O’Callaghan, Eduardo Moya, Eddie M.K. Chung, Eamonn Sheridan, Kim G. Nielsen, Ronald Roepman, Kerstin Bartscherer, Rebecca D. Burdine, Cecilia W. Lo, Heymut Omran, and Hannah M. Mitchison. Ccdc151 mutations cause primary ciliary dyskinesia by disruption of the outer dynein arm docking complex formation. American Journal of Human Genetics, 95:257-274, Sep 2014. URL: https://doi.org/10.1016/j.ajhg.2014.08.005, doi:10.1016/j.ajhg.2014.08.005. This article has 209 citations and is from a highest quality peer-reviewed journal.
Checked with linkml-reference-validator 0.2.1.
| Outcome | Count |
|---|---|
| References checked | 5 |
| Resolved | 5 |
| Unresolved (possible confabulation) | 0 |
| Unverifiable | 0 |
| References weighed for topical relevance | 5 |
| On topic | 3 |
| Off topic | 0 |
All extracted references resolved successfully.
Checked with linkml-term-validator 0.4.5, through the ols: adapter.
| Outcome | Count |
|---|---|
| Terms checked | 37 |
| Resolved | 37 |
| Unresolved (possible confabulation) | 0 |
| Obsolete | 0 |
| Unverifiable | 0 |
| Terms whose name was checked | 3 |
| Terms named correctly | 0 |
| Terms named as a different term | 1 |
| Terms whose name is worth a second look | 2 |
These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:
MONDO:0014465 (2 mentions) - the report calls it "if available"; MONDO calls it primary ciliary dyskinesia 30The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:
GO:0003341 (1 mention) - the report calls it "GO biological process: cilium movement"; GO calls it cilium movement**GO:0031514 (1 mention) - the report calls it "GO cellular component: motile cilium"; GO calls it motile cilium**